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ABSTRACT: Expedient synthetic approaches to the highly functionalized polycyclic alkaloids communesin F and
perophoramidine are described using a uniﬁed approach featuring a key decarboxylative allylic alkylation to access a crucial
and highly congested 3,3-disubstituted oxindole. Described are two distinct, stereoselective alkylations that produce structures in
divergent diastereomeric series possessing the critical vicinal all-carbon quaternary centers needed for each synthesis. Synthetic
studies toward these challenging core structures have revealed a number of unanticipated modes of reactivity inherent to these
complex alkaloid scaﬀolds. Additionally, several novel and interesting intermediates en route to the target natural products, such
as an intriguing propellane hexacyclic oxindole encountered in the communesin F sequence, are disclosed. Indeed, such
unanticipated structures may prove to be convenient strategic intermediates in future syntheses.
■ INTRODUCTION
In 1993, communesin A (1a) was isolated along with
communesin B (1b) from a strain of Penicillium sp. found
growing on a marine alga by the Numata group (Figure 1).1
Communesins A (1a) and B (1b) exhibit antiproliferative
activity against P-388 lymphocytic leukemia cells (ED50 = 3.5
μg/mL and 0.45 μg/mL, respectively).1 In addition, commu-
nesin B (1b) disrupts actin microﬁlaments in cultured
mammalian cells and shows cytotoxic activity against LoVo
and KB cells (MIC values of 2.0 μg/mL and 4.5 μg/mL,
respectively).2 Several other members of the comunesin family,
communesins B−H (1b−h), were disclosed from related
marine fungal strains of Penicillium sp. in the following years.3
With the exception of communesins G (1g) and H (1h), the
communesins show insecticidal activity and antiproliferative
activity against a variety of cancer cells, with communesin B
(1b) being the most potent.1−3 These indole alkaloids contain
several interesting structural features including vicinal all-
carbon quaternary centers, bis-aminal functionalities, and a
complex polycyclic core. The communesins are structurally
unique when compared against other known microﬁlament-
disrupting agents, which are primarily macrolides. Macrolide
microﬁlament-disrupting agents show considerable structural
similarity, and their interactions with actin have been
crystallographically characterized, leading to hypotheses regard-
ing their mechanism of action.4 The unique structure of
communesin B (1b) suggests that it may exhibit a novel
mechanism of action on the cytoskeleton relative to other
microﬁlament-disrupting agents.5a The development of a
uniﬁed synthetic route to the communesins would enable the
understanding of their eﬀects on the cellular cytoskeleton while
addressing the scarcity of naturally occurring sources of the
compounds.
In 2001, an intriguing natural product, nomofungin (2) was
isolated from an unidentiﬁed fungus found on the bark of Ficus
microcarpa by the Hemscheidt group.2 Interestingly, the only
structural diﬀerence between communesin B (1b) and
nomofungin (2) is that communesin B has an aminal moiety
instead of the N,O-acetal moiety present in nomofungin. A
combination of experimental and theoretical exercises led to the
independent discovery by our laboratory and the Funk group
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that the reported structure of nomofungin was incorrect and
that it is actually that of communesin B.5a,b Although the
structure of nomofungin was erroneously assigned, its isolation
and structural revision to that of an older structure can be
viewed as the inception point for all synthetic eﬀorts to the
communesin family members over the past decade. Interest-
ingly, there were no reports of synthetic eﬀorts toward the
communesins from 1993 up to our initial report in 2003.5i
A structurally related compound, perophoramidine (3) was
isolated in 2002 from the ascidian Perophora namei.6 The core
is comparable to the one found in the communesins, albeit in a
higher oxidation state, with the alternate diastereomeric
relationship between the vicinal quaternary carbons and
without the azepine ring system. Perophoramidine (3)
possesses modest cytotoxicity against the HCT 116 human
colon carcinoma cell line (IC50 = 60 μM) and induces
apoptosis.7
These complex, polycyclic, bioactive alkaloids have been the
subject of intense synthetic eﬀorts over the past decade.5
Numerous approaches have been reported in the literature,
including three from our laboratory.5a,c,w Herein, we report the
evolution of an eﬃcient, uniﬁed approach toward the synthesis
of these unique alkaloids.
■ RESULTS AND DISCUSSION
1. Biosynthesis-Inspired Diels−Alder Cycloaddition
Strategy to Communesin F. Our early eﬀorts toward the
communesin structure centered on the laboratory implementa-
tion of our proposed biosynthesis (Scheme 1).5a,c,8 As the key
step in the process, we envisioned a Diels−Alder cycloaddition
to unite the two indole-based fragments by coupling of 5, an N-
methylated derivative of the ergot alkaloid aurantioclavine
(4),9,10 and an o-azaxylylene indolone 6 to generate the bridged
lactam 7. We anticipated that lactam 7 would be highly reactive
due to the poor alignment of the nitrogen lone pair with the
carbonyl.11−13 As such, the pendant amino group would be
expected to easily open the lactam, thus forming spirocycle 8.
Further tailoring would produce communesin A (1a) and B
(1b).
Toward this end, (±)-aurantioclavine was prepared using
known methods,5a,14 and an enantioselective synthesis of
(−)-aurantioclavine utilizing our oxidative kinetic resolution
(OKR) technology was developed.15 We proceeded to develop
an eﬃcient cycloaddition between (±)-indole 9 as a model
coupling partner and benzyl chloride 10 using conditions
previously developed by Steinhagen and Corey16 that resulted
in a mixture of pentacyclic diastereomers (89% yield). Removal
of the tosyl group with magnesium in methanol produced a 2:1
mixture of diastereomers 11 and 12 in 80% combined yield,
with the desired relative stereochemistry evident in the major
diastereomer (cf. 11 and 1a) (Scheme 2).5a
Despite the success of this model system, more advanced
electrophiles (e.g., mesylate 14, cyclopropane 16, or epoxide
1717) did not succumb to cycloaddition conditions (Scheme 3).
Nor have we been successful in the oxidation of 11 and 12 at
C(8), which would provide a functional handle for introduction
of the second quaternary stereocenter.
To obviate the diﬃculties encountered in our attempts to
functionalize C(8), we next considered dienes possessing a
Figure 1. Communesins (1), nomofungin (2), and perophoramidine
(3).
Scheme 1. Biosynthesis-Inspired Approach
Scheme 2. Model Studies for a Diels−Alder Cycloaddtion
Strategy To Construct the Pentacyclic Core Structure
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functional handle at C(8) that could unite diene and dienophile
such as benzisoxazole 19, thereby enabling an intramolecular
Diels−Alder cycloaddition (Scheme 4). Thus, when coupled to
aurantioclavine 4, benzisoxazole 20 would oﬀer a stable o-
methide imine that could react with the indole moiety of
compound 19 in a controlled and intramolecular manner.
Fischer esteriﬁcation of commercially available carboxylic
acid 21 followed by heating in neat sulfuric acid provided the
benzisoxazole acid 20 in 44% yield over two steps (Scheme
5).18 Treatment of benzisoxazole acid 20 with oxalyl chloride
provided the corresponding acid chloride, which was smoothly
coupled with aurantioclavine 4 to furnish carboxamide 22 (91%
yield, two steps). Similarly, 1-methylaurantioclavine 5 reacted
with the acid chloride to aﬀord carboxamide 19 (77% yield, two
steps). Substrates 22 and 19 were subjected to an intra-
molecular Diels−Alder cycloaddition under acidic conditions.19
Unfortunately, the benzisoxazole reacted with the butenyl side
chain of the aurantioclavine core to generate the bridged
polycycles 23 and 24. Nuclear Overhauser eﬀect NMR
spectroscopy (NOESY) studies and X-ray analysis (Figure 2)
demonstrated the relative stereochemistry shown for 24 and
that of 23 was assigned by analogy.
At this point, we turned our attention to synthesizing 3-
bromooxindole 26, which would be a precursor to an o-methide
imine such as reactive intermediate 6, allowing for the
construction of the communesin core according to our original
biosynthesis-inspired model (Scheme 1). Aurantioclavine
derivative 25 was reacted with bromooxindole 26 in an eﬀort
to produce adduct 27 (Scheme 6a). Interestingly, diﬀerent
reactivity was observed in coordinating and noncoordinating
solvents. In THF or acetonitrile, the reaction aﬀorded indole 28
in 69% yield, wherein the oxindole was introduced to position
C(2) of the indole nucleus, presumably via rearrangement of
the initially formed adduct 27 at C(3) (Scheme 6b).
Sulfonylation of indole 28 with o-NsCl under basic conditions
was accompanied by unexpected chlorination of the indole
moiety to aﬀord chloroindolenine 29 (73% yield), the structure
of which was unambiguously conﬁrmed by X-ray crystallog-
raphy (Figure 3). To the best of our knowledge, this constitutes
the ﬁrst use of o-NsCl for chlorination of an indole to provide
the 3-chloroindolenine. On the other hand, the same coupling
of derivatives 25 and 26 in benzene or dichloromethane
furnished indole 28 (24% yield) and two additional undesired
products 30 (32% yield) and 31 (24% yield) (Scheme 6c).
Adduct 30 results from nucleophilic attack at C(6) of the
aurantioclavine indole core, while double adduct 31 is produced
from both C(6) and C(2) functionalization. The structure of
30 was unambiguously determined following preparation of
lactam 32 (Scheme 6d). Subjecting 30 to excess sodium
hydride and o-NsCl conditions functionalized both the oxindole
and indole nitrogens (66% yield) and subsequent reduction of
the azide allowed for cyclization to lactam 32 in 66% yield. The
structure of 32 was conﬁrmed by single-crystal X-ray diﬀraction
(Figure 4).
2. Alkylation Route to Communesin F. Discouraged by
the unsuccessful Diels−Alder cycloaddition-based approaches
to communesin F (1f), we considered an alternative strategy
toward the natural product. In 2007, as a direct result of our
Scheme 3. Attempted Diels−Alder Cycloadditions with
Advanced Electrophiles
Scheme 4. Retrosynthetic Analysis of Communesin F by an
Intramolecular Diels−Alder Cycloaddition
Scheme 5. Intramolecular Diels−Alder Cycloaddition
Figure 2. X-ray structure of bridged polycycle 24.
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eﬀorts toward the communesins and perophoramidine, we
developed a method to generate 3,3-disubstituted oxindoles via
the base-mediated coupling of oxindole electrophiles with
malonate-derived nucleophiles. (Scheme 7a).20 We also
developed an asymmetric variant of this reaction utilizing
copper bis(oxazoline) complexes (Scheme 7b).21
With the method shown in Scheme 7, we devised a new
synthetic strategy that cast our coupling fragments in an
umpolung manner, invoking an electrophilic aurantioclavine
portion and a nucleophilic right-hand fragment. We ﬁrst
pursued this notion in the context of the model azepine 35
(Scheme 8). Treatment of 35 with DBU and a pronucleophile
(e.g., 3622 and 38) produced oxindole adducts (i.e., 37 and 39)
possessing the key C(7)−C(8) linkage in modest, but
encouraging yields. Importantly, adduct 37 was crystalline,
and we conﬁrmed both the new C−C bond as well as the
Scheme 6. Reaction of Aurantioclavine Derivative 25 with
Bromooxindole 26
Figure 3. X-ray structure of chloroindoline 29.
Figure 4. X-ray structure of lactam 32.
Scheme 7. Construction of 3,3-Disubstituted Oxindoles
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relative stereochemistry of the sole diastereomeric isolate via X-
ray analysis.
Having produced the key C(7)−C(8) linkage via an
umpolung strategy, we treated aurantioclavine-derived bromoox-
indole 40 with malonate 41 in the presence of DBU (Scheme
9). Smooth reactivity under our standard conditions led to the
isolation of a single stereoisomeric adduct 42 in 74% yield. To
our delight, oxindole adduct 42 was amenable to single-crystal
X-ray diﬀraction, however, the X-ray analysis surprisingly
revealed that the alkylation occurs with high syn selectivity
relative to the existing isobutenyl substituent (Figure 5). This
result was intriguing, given that in the Diels−Alder cyclo-
addition of the corresponding indole 9 with the o-azaxylylene
derived from benzyl chloride 10, the selectivity at C(7) favored
the anti diastereomer 11 (cf. Schemes 9 and 2).23
Since the undesired relative stereochemistry was obtained in
adduct 42 from the alkylation of azepine 40 and malonate 41,
we explored our strategy in a model system lacking the azepine
ring of the oxindole (Scheme 10). Known silyl ether 4321,22 was
converted into malonate adducts 46 and 47 in 85% and 96%
yield, respectively, under our previously reported conditions in
Scheme 7. Importantly, in the nonazepine system, the eﬃciency
of those alkylations is increased, even in these cases where
vicinal quaternary centers are generated.24 Methylation of
oxindoles 46 and 47 produced 48 and 49 in 99% and 92%
yield, respectively.
Acid-catalyzed desilylation and cyclization of diester 48
proceeded smoothly to furnish lactone 50 in 85% yield as a
single diastereomer (Scheme 11a).25 To our delight, lactone 50
underwent decarboxylative allylic alkylation when treated with
Pd(PPh3)4, yielding 51 in 90% yield as a single diaster-
eomer.26,27 Single-crystal X-ray analysis conﬁrmed that lactone
51 possesses the relative stereochemistry at the vicinal
quaternary carbon centers C(7) and C(8) that is needed for
further elaboration to communesin F (1f). Interestingly, direct
decarboxylative allylic alkylation of diester 49 again provided an
alkylated product (i.e., 52) as a single diastereomer in 78% yield
(Scheme 11b). Through X-ray analysis, we discovered that the
relative stereochemistry at the vicinal quaternary stereocenters
C(20) and C(4) of 52 was complementary to that of the
lactone 51 and thus ideal for elaboration to perophoramidine
(3).
At this time, the underlying reasons for the stereochemical
relationships observed in these two alkylation reactions are
unclear. The fact that the reactions proceed stereodivergently
with high diastereocontrol is quite remarkable. Work toward
building reasonable models for stereoinduction of β-quaternary
tetrasubstituted enolates in both cyclic and acyclic settings as
well as the development of these interesting processes in more
general cases is ongoing. Nevertheless, with the promising
model systems 51 and 52 completed, we next applied our
Scheme 8. Construction of C(7)−C(8) Linkage by
Alkylation Strategy
Scheme 9. Alkylation of Azepine Bromooxindole 40 with
Malonate 41
Figure 5. X-ray structure of oxindole adduct 42.
Scheme 10. Alkylation of 3-Bromooxindole 43
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ﬁndings to expedient formal syntheses of communesin F (1f)
and perophoramidine (3).
3. Formal Synthesis of Communesin F (1f). As depicted
in our retrosynthetic strategy (Scheme 12), communesin F
could be completed from advanced intermediate 53 in Qin’s
synthesis.5g We anticipated the initial disconnection of the
aminal linkage in 53, thereby revealing oxindole and aniline
moieties in 54. Then, the lactam ring in 54 would be excised,
aﬀording lactone 55. We envisioned that the relative stereo-
chemical relationship at C(7) and C(8) of lactone 55 could be
established by employing our decarboxylative allylic alkylation.
The quaternary center on oxindole 56 was disassembled into 3-
bromooxindole 57 and diallyl malonate 44.
In the forward synthetic sense, our eﬀorts toward
communesin F commenced with the elaboration of 4-
bromooxindole 58 to diallyl malonate 60 (Scheme 13).
Treatment of 4-bromoindole 58 with oxalyl chloride and
methanol provided an oxoacetate (78% yield, two steps), which
Scheme 11. Model Studies for Construction of the Vicinal
Quaternary Centers
Scheme 12. Retrosynthesis of Communesin F (1f)
Scheme 13. Development of the Vicinal Quaternary Center
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was reduced to the corresponding primary alcohol 59 with
LiAlH4 in 91% yield.
5g Silylation of the primary alcohol with
TIPSCl (98% yield) and subsequent oxidation with pyridinium
tribromide aﬀorded dibromooxindole 57 in 89% yield.28
Despite the extra steric encumbrance of C(4) substitution,
we were delighted to ﬁnd that smooth coupling of
dibromooxindole 57 with malonate 44 produced a 3,3-
disubstituted oxindole in 95% yield. Protection of the oxindole
with MeI delivered adduct 60 in 92% yield. Microwave assisted
lactonization of diester 60 with p-TsOH proceeded smoothly to
furnish lactone 61 as a single diastereomer (85% yield).
Gratifyingly, decarboxylative allylic alkylation constructed the
quaternary center at C(8) of compound 62 as a single
diastereomer in 97% yield under Pd(PPh3)4 catalysis. The
relative stereochemistry at C(7) and C(8) of 61 and 62 was
unambiguously conﬁrmed by X-ray analysis.
Although ozonolysis of alkene 62 delivered aldehyde 63 in
94% yield, attempted reductive amination of aldehyde 63 did
not produce the desired γ−lactam 66 (Scheme 14). Upon
treatment of aldehyde 63 with p-methoxybenzylammonium
acetate and sodium cyanoborohydride, amine intermediate 64
was likely produced.29 Instead of opening the lactone directly
(path a), nucleophilic attack by the newly generated amine at
the oxindole moiety (path b), and subsequent ring-shift
tautomerization delivered dihydroquinolinone 65 in 67% yield.
Alternatively, we found that lactam 54 (an analogue of 66)
could be obtained via the reaction sequence summarized in
Scheme 15. The nitro group on compound 62 was reduced to
the aniline, which resulted in concomitant lactone ring opening
to furnish a bis-oxindole 67 in 80% yield. Protection of the
primary alcohol with TIPSCl (90% yield) and protection of the
oxindole nitrogen with methyl chloroformate aﬀorded
carbamate 68 in 98% yield. Ozonolysis of alkene 68 generated
aldehyde 69 (94% yield),30 which underwent subsequent
reductive amination and selective lactamization with the
electron-deﬁcient oxindole to aﬀord γ-lactam 54 in 95% yield.
With lactam 54 in hand, we envisioned that the piperidine D
ring of 70 would be prepared by AlH3−Me2NEt mediated
reductive cyclization (Scheme 16).21,31 To our disappointment,
treatment of lactam 54 with AlH3−Me2NEt produced
undesired pyrrolidinoindoline derivative 71 as a single
diastereomer in 61% yield resulting from chemoselective
reduction of the N-PMB-lactam in the presence of the
oxindole. After cleavage of the TIPS group by TBAF (98%
yield),32 the PMB group was removed with DDQ33 to provide
alcohol 72. The structure of the pentacyclic heterocycle 72 was
conﬁrmed by X-ray analysis (Figure 6).
Having failed on our initial exploration, alternative conditions
for construction of the piperidine D ring were next explored.
Scheme 14. Ozonolysis and Reductive Amination of Lactone
62
Scheme 15. Synthesis of Lactam 54
Scheme 16. Reductive Cyclization of Lactam 54 with AlH3-
Me2NEt
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Treatment of the lactam 54 with LiAlH4
34 produced
debrominated compound 73 in 83% yield (Scheme 17a). X-
ray analysis of compound 73 showed a hydrogen-bonding
interaction between the carbonyl group of the PMB-protected
amide and the NH group of the carbamate. We reasoned that
the undesired pyrrolidine was formed preferentially to the
piperidine due to the close proximity of the carbamate NH and
the carbonyl group of the PMB-protected amide. Next, a
reductive cyclization reaction was attempted by treatment of 54
with Tf2O and NaBH4 to construct the piperidine ring. To our
surprise, treatment of lactam 54 with Tf2O provided the PMB-
protected hexacyclic oxindole 76 in 95% yield (Scheme 17b).
The PMB-protected amide of 54 was activated by Tf2O to
provide 74, and nucleophilic attack by the aniline functionality
furnished pyrrolidinoindoline derivative 75. After the TIPS
group was removed under the reaction conditions, the resultant
hydroxyl group attacked the amidinium to generate the
propellane structure of hexacyclic oxindole 76. After cleavage
of the PMB group using DDQ, the propellane structure of
hexacyclic oxindole 77 was conﬁrmed using X-ray analysis.
Despite this unexpected turn of events, we envisaged that the
desired aminal 81 could be accessed from the propellane
compound 76 using suitable conditions, since the oxidation
state at C(9) of 76 is identical to that of the desired aminal 81
(Scheme 18). Moreover, the reactive N-PMB-pyrrolidinone in
54 is now protected by the propellane structure of 76, thus
leaving the oxindole as the only reducible carbonyl group.
Fortunately, after extensive experimentation, we were pleased
to ﬁnd that reductive cyclization of hexacyclic oxindole 76
could be accomplished with DIBAL and Et2AlCl to furnish
aminal 81 in 87% yield (Scheme 18). Presumably, the oxindole
of 76 was reduced by DIBAL to provide 78, and rearrangement
of the propellane structure generated iminium 79. After the
workup, water attacked the iminium moiety of 79 to aﬀord
aniline 80, and the resultant aniline group attacked the iminium
of 80 to construct aminal 81. In the last stage of the synthesis,
we screened a variety of reaction conditions to remove the
PMB group on the lactam 81 (e.g., DDQ, CAN, TFA, etc.), but
surprisingly, removal of the PMB group failed under all
conditions attempted. This unexpected turn was particularly
insidious since the PMB group was easily removed from
hexacyclic oxindole 76 by DDQ (Scheme 17). The cleavage of
allyl or benzyl groups were also examined, but disappointingly,
cleavage of these groups on the lactam was similarly
unsuccessful under several conditions.35
Given the diﬃculty of removal of PMB, allyl, and benzyl
groups, our attention turned to exploring the o-nitrobenzyl
group as a protecting group. However, subjecting the hexacyclic
oxindole 77 to o-nitrobenzyl bromide under basic conditions to
produce the o-nitrobenzyl-protected propellane hexacyclic
oxindole turned out to be challenging. Thus, we next
investigated reductive amination of aldehyde 69 and were
pleased to ﬁnd that treatment of 69 with o-nitrobenzylammo-
nium acetate 82 furnished lactam 83 in 97% yield (Scheme 19).
Formation of the o-nitrobenzyl-protected propellane hexacyclic
oxindole using Tf2O (75% yield) was followed by reductive
cyclization with DIBAL and Et2AlCl to furnish aminal 84 in
60% yield. To our delight, we found that removal of the o-
nitrobenzyl group could be achieved by photolysis/irradiation
at 350 nm in 40% yield.36 Surprisingly, we discovered that
removal of the o-nitrobenzyl group to produce compound 53
was also accomplished using 20% aq NaOH in methanol at 75
°C in 70% yielda previously unknown deprotection
protocol.37 Aminal 53 has been advanced by the Qin group
to communesin F,5g thus completing our formal synthesis of
the natural product.
4. Formal Synthesis of Perophoramidine (3). Our
retrosynthetic analysis of perophoramidine (3) was based on
our previously established expedient synthesis of oxindole
derivative 52 (Scheme 20). We speculated that the aminal and
lactam ring functionalities of pentacycle 85, an intermediate in
Funk’s synthesis,5o could be cleaved, thereby leading to
aldehyde 86. The N−C bond of the 6-bromooxindole moiety
in 86 was excised to arrive at nitroarene 52. The construction of
the contiguous quaternary centers at C(20) and C(4) of allyl
ester 52 with the proper relative stereochemistry was accessed
by decarboxylative allylic alkylation as previously described
(Scheme 11b).
Carbamate 88 was obtained by reduction of nitroarene 52
with titanium chloride and simultaneous oxindole formation38
to furnish the bis-oxindole moiety 87 in 91% yield followed by
protection with Boc anhydride in 85% yield. Ozonolysis of
oleﬁn 88 produced aldehyde 86 in 90% yield. Reductive
amination of aldehyde 86 with o-nitrobenzylammonium acetate
82 resulted in an amine that underwent in situ lactam
formation to aﬀord oxindole lactam 89 in 91% yield (Scheme
21)
Initially, we attempted to generate the o-nitrobenzyl
protected propellane hexacyclic oxindole 90 under analogous
conditions to those used in our formal synthesis of
communesin F on the pseudo-diastereomeric series (vide
supra). However, treatment of lactam 89 with Tf2O yielded an
unexpected azepine 91 in 70% yield (Scheme 22). Both the Boc
and the TIPS groups on amide 89 were removed under the
reaction conditions, and the resulting primary alcohol was
presumably converted to the corresponding triﬂate. Finally, the
aniline likely attacked the newly formed triﬂate to form azepine
91.
After extensive experimentation, we discovered that in
contrast to the communesin system, the desired reductive
cyclization in the perophoramidine diastereomer occurred
directly with AlH3−Me2NEt
31 to furnish cyclization product
92 in 42% yield (66% yield based on recovered starting
material) (Scheme 23). The indoline methyl group was
converted to a formyl group using PDC oxidation in 62%
yield (93% yield based on recovered starting material).39 To
our delight, an attempt to remove the formyl group with 20%
aq NaOH at 75 °C resulted in removal of both the formyl
group and the o-nitrobenzyl group to produce aminal 85 in
50% yield.37,40 This molecule was previously advanced by the
Funk group to perophoramidine5o and constitutes an expedient
formal synthesis of the natural product.
Figure 6. X-ray structure of pyrrolidinoindoline 72.
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Scheme 17. Attempted Reductive Cyclization of Lactam 54
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■ CONCLUSION
In conclusion, we have conducted synthetic studies toward
unique polycyclic alkaloids and completed formal syntheses of
communesin F (1f) in 9% overall yield over 17 steps and
perophoramidine (3) in 6% overall yield (13% overall yield,
based on recovered starting material) over 10 steps using a
uniﬁed stereodivergent alkylation approach. The all-carbon
quaternary center on the oxindole was established via stabilized
enolate alkylation of 3-bromooxindoles, a method previously
developed by our laboratory and now shown to be quite
versatile even in particularly sterically challenging situations.
The complementary relative stereochemistry of the two
contiguous quaternary stereogenic centers found in commune-
sin F (1f) and perophoramidine (3), respectively, was
established by substrate controlled diastereoselective decarbox-
ylative allylic alkylation. A reductive amination approach
furnished the A ring, and reductive cyclization produced the
D ring for both communesin F (1f) and perophoramidine (3).
En route to the evolution of our eventual successful strategy, we
have discovered a method to convert an indole to a 3-
Scheme 18. Synthesis of Aminal 81
Scheme 19. Completion of Formal Synthesis of
Communesin F
Scheme 20. Retrosynthesis of Perophoramidine (3)
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chloroindolenine using a mild reagent such as o-NsCl during
the synthesis. In addition, previously unknown, mild and
eﬃcient deprotection conditions for the o-nitrobenzyl group on
the lactam were discovered. Further studies to rationalize
unprecedented complementary selectivity by Pd-catalyzed
allylic alkylation reactions are currently in progress.
■ EXPERIMENTAL SECTION
N-(2-(1-Hydroxy-2-(methoxymethoxy)ethyl)phenyl)-4-meth-
ylbenzenesulfonamide (13). To a solution of 4-methyl-N-(2-
vinylphenyl)benzenesulfonamide (SI-1) (6.11 g, 22.4 mmol, 1.00
equiv) in THF (140 mL) and water (70 mL) were added N-
methylmorpholine N-oxide (5.96 g, 50.8 mmol, 2.30 equiv) and
osmium tetroxide (11.6 mg, 43.9 mmol, 0.002 equiv). After addition,
reaction was stirred for 3 days. The reaction was concentrated to
approximately 50 mL under reduced pressure and then extracted with
a mixture ether and THF (1:1) (3 × 45 mL). The organic layers were
dried over sodium sulfate, and the solvent was removed under reduced
pressure. Impurities were removed by washing solid with dichloro-
methane to aﬀord diol SI-2 (5.43 g, 80% yield) as a white solid: Rf =
0.13 (1:1 hexane/EtOAc); 1H NMR (300 MHz, CDCl3) δ 8.47 (s,
1H), 7.71 (d, J = 8.3 Hz, 2H), 7.39 (dd, J = 8.1, 1.1 Hz, 1H), 7.25−
7.18 (m, 3H), 7.15−7.02 (m, 2H), 4.82 (t, J = 6.5 Hz, 1H), 3.66−3.57
(m, 2H), 2.97 (br, s, 1H), 2.39 (s, 3H), 1.98 (br, s, 1H); 13C NMR (75
MHz, CDCl3) δ 144.1, 137.1, 136.3, 129.9, 129.8, 129.2, 128.5, 127.4,
127.0, 122.2, 74.78, 66.0, 21.8; IR (neat ﬁlm NaCl) 3271, 1318, 1150
cm−1; HRMS (MM: ESI-APCI+) m/z calcd for C15H18NO4S [M +
H]+ 308.0951, found 308.0967.
To a solution of diol SI-2 (500 mg, 1.63 mmol, 1.00 equiv) in
toluene (70 mL) was added dibutyltin dimethoxide (410 μL, 1.79
mmol, 1.10 equiv). The ﬂask was ﬁtted with a short path distillation
apparatus, and approximately half of the solvent was removed by
distillation. To this solution were added MOMCl (136 μL, 1.79 mmol,
1.10 equiv) and tetrabutylammonium iodide (900 mg, 2.44 mmol, 1.50
equiv). After addition, the reaction was stirred for 12 h, and then brine
was added to this solution. The reaction mixture was extracted with
EtOAc (3 × 50 mL). The combined organic phases were dried over
MgSO4 and concentrated in vacuo. The residue was puriﬁed by ﬂash
column chromatography (3:1 → 1:1 hexanes/EtOAc) to aﬀord
alcohol 13 (513 mg, 90% yield, two steps) as a white solid: Rf = 0.27
(1:1 hexane/EtOAc); 1H NMR (300 MHz, CDCl3) δ 8.76 (s, 1H),
7.72 (d, J = 8.5 Hz, 2H), 7.50 (d, J = 8.0 Hz, 1H), 7.27−7.20 (m, 3H),
7.11−7.02 (m, 2H), 4.83−4.78 (m, 1H), 4.64 (s, 2H), 3.60 (dd, J =
10.5, 3.5 Hz, 1H), 3.48−3.41 (m, 2H), 3.39 (s, 3H), 2.39 (s, 3H); 13C
NMR (75 MHz, CDCl3) δ 143.9, 137.1, 136.3, 129.7, 129.5, 128.9,
128.2, 127.2, 124.7, 122.0, 97.0, 73.3, 72.4, 55.6, 21.6; IR (neat ﬁlm
NaCl) 3233, 2932, 1598, 1497, 1335, 1161 cm−1; HRMS (MM: ESI-
APCI+) m/z calcd for C17H22NO5S [M + H]
+ 352.1213, found
352.1219.
Methyl 2′-Oxospiro[cyclopropane-1,3′-indoline]-2-carboxy-
late (16). A ﬂame-dried ﬂask (25 mL) equipped with a Teﬂon stirbar
was charged with sodium hydride (60% dispersion in mineral oil, 22
mg, 0.55 mmol, 1.10 equiv), which was washed 3 times with dry
hexanes. Then, DMSO (5.5 mL) and trimethylsulfoxonium iodide
(119 mg, 0.58 mmol, 1.20 equiv) were added. To this solution was
added methyl (E)-2-(2-oxoindolin-3-ylidene)acetate (SI-3) (100 mg,
0.49 mmol, 1.00 equiv) in a solution of DMSO (2.5 mL). After
Scheme 21. Synthesis of Amide 89
Scheme 22. Formation of Azepine 91 Using Tf2O
Scheme 23. Completion of Formal Synthesis of
Perophoramidine
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addition, the reaction was stirred for 2 h, and then the temperature was
raised to 50 °C. The reaction was complete after another hour. Brine
was added and then the mixture was extracted with EtOAc (3 × 5
mL). The combined organic phases were dried over MgSO4 and
concentrated in vacuo. The residue was puriﬁed was by ﬂash column
chromatography (3:1→ 1:1 hexanes/EtOAc) to aﬀord oxindole 16 as
two diastereomers. Diastereomer 1: (44.7 mg, 42% yield).
Diastereomer 2: (28.6 mg, 27% yield). Diastereomer 1: Rf = 0.52
(1:1 hexane/EtOAc); 1H NMR (300 MHz, CDCl3) δ 8.28 (br, s, 1H),
7.34 (d, J = 7.7 Hz, 1H), 7.22 (dd, J = 7.7, 1.3 Hz, 1H), 7.02 (dd, J =
7.7, 1.1 Hz, 1H), 6.99−6.93 (m, 1H), 3.69 (s, 3H), 2.72 (dd, J = 8.6,
7.4 Hz, 1H), 2.16 (dd, J = 7.4, 4.5 Hz, 1H), 2.04 (dd, J = 8.6, 4.4 Hz,
1H); 13C NMR (75 MHz, CDCl3) δ 177.5, 169.3, 141.8, 127.9, 126.4,
123.0, 122.4, 110.3, 52.4, 34.3, 32.9, 21.1; IR (neat ﬁlm NaCl) 3214,
1712, 1622, 1470, 1209 cm−1; HRMS (MM: ESI-APCI+) m/z calcd
for C12H12NO3 [M + H]
+ 218.0812, found 218.0825. Diastereomer 2:
Rf = 0.45 (1:1 hexane/EtOAc);
1H NMR (300 MHz, CDCl3) δ 7.99
(br, s, 1H), 7.25−7.19 (m, 1H), 7.02 (td, J = 7.6, 1.0 Hz, 1H), 6.93 (d,
J = 7.8 Hz, 1H), 6.85−6.80 (m, 1H), 3.75 (s, 3H), 2.66 (t, J = 8.3 Hz,
1H), 2.39 (dd, J = 5.0, 8.0 Hz, 1H), 1.84 (dd, J = 5.0, 8.6 Hz, 1H); 13C
NMR (75 MHz, CDCl3) δ 176.0, 167.7, 141.1, 129.5, 188.0, 122.4,
118.9, 110.3, 52.6, 33.5, 32.9, 21.3; IR (neat ﬁlm NaCl) 3256, 1739,
1710 cm−1; HRMS (MM: ESI-APCI+) m/z calcd for C12H12NO3 [M
+ H]+ 218.0812, found 218.0828.
Benzo[c]isoxazole-3-carboxylic Acid 20. A ﬂame-dried ﬂask
(500 mL) equipped with a Teﬂon stirbar was charged with 2-
nitrophenylacetic acid 21 (10.0 g, 55.2 mmol, 1.00 equiv), ethanol (60
mL), sulfuric acid (200 μL), and toluene (280 mL). The ﬂask was
ﬁtted with a condenser, and the solution was reﬂuxed for 14 h. The
solvent was removed under reduced pressure and sulfuric acid (280
mL) was added. After addition, the reaction was heated to 110 °C and
stirred for 90 min. The solution was then poured onto ice (600 g), and
the mixture was extracted with ether (3 × 200 mL). The combined
organic layers were dried over MgSO4 and concentrated in vacuo.
Puriﬁcation was performed via crystallization from water to aﬀord acid
20 (3.94 g, 44% yield, 2 steps) as an oﬀ-white solid: 1H NMR (300
MHz, acetone-d6) δ 10.82 (br, s, 1H), 7.94 (d, J = 9.0 Hz, 1H), 7.75
(d, J = 10.0 Hz, 1H), 7.50 (dd, J = 6.5, 9.5 Hz, 1H), 7.34 (dd, J = 7.0,
8.5 Hz, 1H); 13C NMR (75 MHz, acetone-d6) δ 158.5, 158.1, 155.3,
132.4, 128.8, 121.4, 121.0, 116.7; IR (neat ﬁlm NaCl) 2360, 1731,
1301, 1231, 1189, 753 cm−1; HRMS (MM: ESI-APCI+) m/z calcd for
C8H6NO3 [M + H]
+ 164.0342, found 164.0341.
6-Methyl-1-(2-methylprop-1-en-1-yl)-2,3,4,6-tetrahydro-1H-
azepino[5,4,3-cd]indole 5. To a solution of (E)-2-methyl-4-(3-(2-
nitroethyl)-1H-indol-4-yl)but-3-en-2-ol (SI-4) (386 mg, 1.41 mmol,
1.00 equiv) in THF (14 mL) was added methyl iodide (875 μL, 14.1
mmol, 10.0 equiv) at 0 °C. Sodium hydride (60% dispersion in
mineral oil, 562 mg, 14.5 mmol, 10.3 equiv) was then added to the
solution, and the mixture was stirred for 25 min at 23 °C. The reaction
was quenched with satdrated ammonium hydroxide solution and
extracted with EtOAc (3 × 10 mL). The combined organic layers were
dried over MgSO4 and concentrated in vacuo. The residue was puriﬁed
by ﬂash column chromatography (3:1 → 2:1 hexanes/EtOAc) to
aﬀord (E)-2-methyl-4-(1-methyl-3-(2-nitroethyl)-1H-indol-4-yl)but-3-
en-2-ol (SI-5) (363.5 mg, 90% yield) as a yellow solid.
To a solution of nitro compound SI-5 (512 mg, 1.78 mmol, 1.00
equiv) in MeOH (125 mL) and 2 N HCl (40 mL) was added
amalgamated zinc, which had been formed from zinc dust (6.5 g, 98.3
mmol, 55.0 equiv) and mercuric chloride (1.10 g, 3.55 mmol, 2.00
equiv) in 2 N HCl and subsequently rinsed with MeOH. The mixture
was stirred at reﬂux for 3 h. The reaction was then decanted from the
remaining amalgam and then basiﬁed to pH >10. The solid was
removed by ﬁltration, and the resulting solution was extracted with
dichloromethane (3 × 100 mL). The combined organic layers were
dried over MgSO4 and concentrated in vacuo. The residue was puriﬁed
by ﬂash column chromatography (18:1 CH2Cl2/MeOH) to aﬀord 1-
methylaurantioclavine 5 (258 mg, 60% yield) as a yellow oil: Rf = 0.30
(18:1 CH2Cl2/MeOH);
1H NMR (300 MHz, CDCl3) δ 7.19−7.12
(m, 2H), 6.89−6.83 (m, 2H), 5.48 (d, J = 9.0 Hz, 1H), 4.92 (d, J = 9.0
Hz, 1H), 3.76 (s, 3H), 3.62−3.54 (m, 1H), 3.13−3.02 (m, 3H), 2.26
(br, s, 1H), 1.86 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 138.5, 137.8,
133.3, 127.7, 125.9, 121.1, 117.4, 114.2, 107.3, 62.6, 48.9, 32.7, 30.8,
25.9, 18.4; IR (neat ﬁlm NaCl) 3332, 2910, 1554, 1455 cm−1; HRMS
(MM: ESI-APCI+) m/z calcd for C16H21N2 [M + H]
+ 241.1699,
found 241.1712.
Benzo[c]isoxazol-3-yl(1-(2-methylprop-1-en-1-yl)-1,3,4,6-
tetrahydro-2H-azepino[5,4,3-cd]indol-2-yl)methanone (22). To
a solution of 2,1-benzisoxazole-3-carboxylic acid (20) (262 mg, 1.60
mmol, 1.25 equiv) in dichloromethane (5 mL) was added oxalyl
chloride (420 μL, 4.81 mmol, 3.80 equiv) and then a small amount of
DMF (∼20 μL). The reaction was stirred for 1 h, and then the solvent
was removed under reduced pressure; the residue was evaporated from
benzene (2 mL) to remove excess reagent. Dichloromethane (10 mL)
and triethylamine (537 μL, 3.85 mmol, 3.00 equiv) were added, and to
this solution was added aurantioclavine 4 (290 mg, 1.28 mmol, 1.00
equiv). After addition, the reaction was stirred for 60 min, and then
brine was added. The resulting solution was extracted with EtOAc (3
× 7 mL). The combined organic layers were dried over MgSO4 and
concentrated in vacuo. The residue was puriﬁed by ﬂash column
chromatography (3:1→ 1:1 hexanes/EtOAc) to aﬀord amide 22 (435
mg, 91% yield, 2 steps) as a white solid. Rf = 0.72 (1:2 hexanes/
EtOAc). (Due to the distinct presence of rotameric isomers, the 1H
NMR and 13C NMR contained extra peaks. See the attached spectrum,
Supporting Information): 1H NMR (300 MHz, CDCl3) δ 9.00−8.86
(m, 2H), 7.98 (dq, J = 8.9, 0.9 Hz, 1H), 7.71−7.57 (m, 3H), 7.35−
7.27 (m, 2H), 7.25−7.22 (m, 1H), 7.22−7.16 (m, 3H), 7.15−7.07 (m,
2H), 7.07−7.01 (m, 2H), 7.01−6.94 (m, 2H), 6.90−6.83 (m, 2H),
6.70 (d, J = 7.5 Hz, 1H), 5.48 (ddq, J = 7.9, 2.8, 1.6 Hz, 2H), 4.82−
4.66 (m, 2H), 4.07 (ddd, J = 15.4, 10.0, 5.8 Hz, 1H), 3.82 (td, J = 13.0,
2.6 Hz, 1H), 3.60−3.46 (m, 1H), 3.23−3.12 (m, 3H), 1.96 (d, J = 1.3
Hz, 3H), 1.79 (d, J = 1.5 Hz, 3H), 1.73 (d, J = 1.6 Hz, 2H), 1.64 (d, J
= 1.3 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 158.5, 158.4, 157.9,
157.8, 156.9, 156.8, 137.7, 137.4, 137.2, 136.9, 135.2, 135.1, 131.5,
131.4, 126.4, 126.1, 124.7, 124.3, 123.9, 123.8, 122.1, 121.9, 121.8,
121.7, 121.1, 121.0, 119.9, 118.3, 117.5, 114.9, 113.3, 112.6, 110.1,
109.9, 61.0, 57.5, 44.5, 43.1, 29.1, 25.9, 25.8, 25.7, 18.9, 18.2; IR (neat
ﬁlm NaCl) 3325, 2914, 2246, 1730, 1616, 1447 cm−1; HRMS (MM:
ESI-APCI+) m/z calcd for C23H22N3O2 [M + H]
+ 372.1707, found
372.1721.
Benzo[c]isoxazol-3-yl(6-methyl-1-(2-methylprop-1-en-1-yl)-
1,3,4,6-tetrahydro-2H-azepino[5,4,3-cd]indol-2-yl)methanone
(19). To a solution of 2,1-benzisoxazole-3-carboxylic acid (20) (37.5
mg, 0.229 mmol, 1.10 equiv) in dichloromethane (500 μL) was added
oxalyl chloride (59 μL, 0.676 mmol, 3.30 equiv) and then a small
amount of DMF (∼1 μL). The reaction was stirred for 1 h, and then
the solvent was removed under reduced pressure. The residue was
evaporated from benzene (1 mL) to remove excess reagent.
Dichloromethane (1.1 mL) and triethylamine (30 μL, 0.215 mmol,
1.03 equiv) were added, and to this solution was added 1-
methylaurantioclavine (5) (50.0 mg, 0.208 mmol, 1.00 equiv). After
addition, the reaction was stirred for 60 min, and then brine was
added. The resulting solution was extracted with EtOAc (3 × 1.5 mL).
The combined organic layers were dried over MgSO4 and
concentrated in vacuo. The residue was puriﬁed by ﬂash column
chromatography (3:1→ 2:1 hexanes/EtOAc) to aﬀord amide 19 (61.6
mg, 77% yield, 2 steps) as a white solid: Rf = 0.79 (1:2 hexanes/
EtOAc). (Due to the distinct presence of rotameric isomers, the 1H
NMR and 13C NMR contained extra peaks. See the attached spectrum,
Supporting Information): 1H NMR (300 MHz, CDCl3) δ 8.00 (dt, J =
8.9, 1.1 Hz, 1H), 7.71 (dt, J = 8.9, 1.1 Hz, 1H), 7.61 (ddt, J = 10.9, 9.1,
1.0 Hz, 2H), 7.34−7.26 (m, 3H), 7.24−7.16 (m, 5H), 7.12−7.04 (m,
2H), 7.00 (ddd, J = 8.9, 6.4, 0.8 Hz, 1H), 6.93−6.86 (m, 2H), 6.81 (d,
J = 1.2 Hz, 1H), 6.72 (d, J = 7.5 Hz, 1H), 5.50 (ddt, J = 7.4, 2.8, 1.4
Hz, 2H), 4.83−4.64 (m, 2H), 4.13−4.00 (m, 1H), 3.81 (td, J = 13.0,
2.6 Hz, 1H), 3.69 (d, J = 8.6 Hz, 6H), 3.64−3.45 (m, 1H), 3.26−3.09
(m, 3H), 1.98 (d, J = 1.3 Hz, 3H), 1.83−1.78 (m, 3H), 1.74 (d, J = 1.4
Hz, 2H), 1.65 (d, J = 1.3 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ
158.5, 158.5, 157.7, 157.6, 156.9, 156.8, 137.8, 137.7, 137.6, 136.8,
135.7, 135.6, 131.3, 131.2, 126.5, 126.3, 125.9, 124.8, 124.4, 124.3,
124.2, 122.1, 121.6, 121.5, 121.2, 121.1, 120.0, 118.1, 117.3, 115.0,
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114.9, 112.3, 111.7, 107.9, 107.7, 60.9, 57.3, 44.5, 43.1, 32.6, 29.0, 25.9,
25.7, 18.9, 18.2; IR (neat ﬁlm NaCl) 2913, 2245, 1615, 1455, 1410
cm−1; HRMS (MM: ESI-APCI+) m/z calcd for C24H24N3O2 [M +
H]+ 386.1863, found 386.1877.
15,15-Dimethyl-4,6,7,15,15a,15b-hexahydro-9H-9a,14-
epoxyindolo[4″,3″:3′,4′,5′]azepino[1′,2′:1,2]pyrrolo[3,4-c]-
quinolin-9-one (23). A ﬂame-dried vial (20 mL) equipped with a
Teﬂon stirbar was charged with amide 22 (100 mg, 0.269 mmol, 1.00
equiv) and cooled to 0 °C. To this reaction mixture was added a 0.5 M
solution of HCl in MeOH (2.7 mL, generated from addition of acetyl
chloride to methanol at 0 °C) at 0 °C. The mixture was stirred for 1 h
and then warmed to 23 °C over 30 min. The solvent was then
removed under reduced pressure. Puriﬁcation was performed by
washing the solid with dichloromethane to aﬀord indole 23 (31.1 mg,
31% yield) as a white solid: Rf = 0.22 (1:1 hexane/EtOAc);
1H NMR
(300 MHz, DMSO) δ 11.05 (d, J = 2.5 Hz, 1H), 7.35−7.17 (m, 6H),
7.09 (t, J = 7.7 Hz, 1H), 6.61 (dt, J = 7.4, 1.0 Hz, 1H), 5.47 (d, J = 6.6
Hz, 1H), 4.21 (dt, J = 13.2, 3.7 Hz, 1H), 3.45 (td, J = 13.2, 12.5, 2.4
Hz, 1H), 3.15 (dt, J = 16.0, 3.0 Hz, 1H), 3.08−2.94 (m, 1H), 2.37 (dd,
J = 6.6, 0.9 Hz, 1H), 1.77 (s, 3H), 1.03 (s, 3H); 13C NMR (75 MHz,
DMSO) δ 164.3, 153.0, 139.6, 137.0, 134.6, 127.3, 126.6, 123.7, 122.6,
121.4, 118.6, 118.0, 115.2, 112.7, 110.2, 96.4, 70.1, 63.1, 61.2, 44.4,
26.9, 26.6, 26.0; IR (neat ﬁlm NaCl) 3314, 1681, 753 cm−1; HRMS
(MM: ESI-APCI+) m/z calcd for C23H22N3O2 [M + H]
+ 372.1707,
found 372.1710.
4,15,15-Trimethyl-4,6,7,15,15a,15b-hexahydro-9H-9a,14-
epoxyindolo[4″,3″:3′,4′,5′]azepino[1′,2′:1,2]pyrrolo[3,4-c]-
quinolin-9-one (24). A ﬂame-dried vial (20 mL) equipped with a
Teﬂon stirbar was charged with amide 19 (100 mg, 0.259 mmol, 1.00
equiv) and cooled to 0 °C. To this solution was added a 0.5 M
solution of HCl in MeOH (2.6 mL, generated from addition of acetyl
chloride to methanol at 0 °C) at 0 °C. The mixture was stirred for 1 h
and then warmed to 23 °C over 30 min. The solvent was then
removed under reduced pressure. Puriﬁcation was performed via ﬂash
column chromatography (3:1 → 1:1 hexanes/EtOAc) to aﬀord indole
24 (101 mg, 99% yield) as a white solid: Rf = 0.29 (1:1 hexane/
EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.33−7.32 (m, 1H), 7.24−
7.14 (m, 5H), 7.00 (s, 1H), 6.76−6.73 (m, 1H), 5.51 (d, J = 6.5 Hz,
1H), 4.57−4.50 (m, 1H), 3.80 (s, 3H), 3.41 (dd, J = 12.4, 10.0 Hz,
1H), 3.33−3.24 (m, 1H), 3.19−3.12 (m, 1H), 2.57 (d, J = 6.5 Hz,
1H), 1.95 (s, 3H), 1.18 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 165.4,
153.5, 139.8, 137.9, 135.6, 127.5, 127.0, 126.9, 124.6, 121.9, 119.1,
118.4, 115.9, 113.4, 108.4, 97.2, 70.9, 64.1, 61.9, 45.2, 33.0, 27.5, 27.2,
26.6; IR (neat ﬁlm NaCl) 3315, 2932, 1699, 1456, 1317, 754 cm−1;
HRMS (MM: ESI-APCI+) m/z calcd for C24H24N3O2 [M + H]
+
386.1863, found 386.1867.
2,2,2-Triﬂuoro-1-(1-(2-methylprop-1-en-1-yl)-1,3,4,6-tetra-
hydro-2H-azepino[5,4,3-cd]indol-2-yl)ethan-1-one (25). To a
solution of aurantioclavine 4 (882 mg, 3.90 mmol, 1.00 equiv) in THF
(14 mL) were added triethylamine (820 μL, 5.88 mmol, 1.50 equiv)
and triﬂuoroacetic anhydride (606 μL, 4.29 mmol, 1.10 equiv) at 0 °C.
The reaction was completed immediately, so it was quenched with
methanol. The solvent was then removed under reduced pressure.
Puriﬁcation was performed via ﬂash column chromatography (9:1 →
3:1 hexanes/EtOAc) to aﬀord the N-triﬂuoroacetate-aurantioclavine
25 (1.03 g, 82% yield) as a yellow foam:Rf = 0.30 (3:1 hexanes/
EtOAc). (Due to the distinct presence of rotameric isomers, the 1H
NMR and 13C NMR contained extra peaks. See the attached spectrum,
Supporting Information): 1H NMR (300 MHz, CDCl3) δ 8.50 (s,
2H), 7.31−7.24 (m, 2H), 7.16 (dd, J = 8.1, 7.2 Hz, 2H), 7.03−6.95
(m, 3H), 6.93−6.86 (m, 2H), 6.23 (d, J = 7.8 Hz, 1H), 5.46−5.31 (m,
2H), 4.39 (dt, J = 13.4, 3.5 Hz, 1H), 4.18−4.06 (m, 1H), 4.05−3.91
(m, 1H), 3.83 (td, J = 13.2, 2.9 Hz, 1H), 3.43 (dddd, J = 17.4, 13.1,
4.2, 1.7 Hz, 1H), 3.29−3.18 (m, 2H), 3.09 (dt, J = 16.5, 2.8 Hz, 1H),
1.91 (d, J = 1.3 Hz, 3H), 1.86 (d, J = 1.4 Hz, 3H), 1.77 (t, J = 1.9 Hz,
6H); 13C NMR (75 MHz, CDCl3) δ 157.5, 157.0, 156.8, 156.3, 138.5,
137.4, 137.2, 137.2, 135.1, 134.4, 124.3, 123.9, 123.5, 123.3, 122.1,
121.9, 121.8, 119.0, 118.8, 118.5, 117.1, 115.2, 115.0, 113.1, 112.6,
110.3, 110.1, 60.7, 60.6, 58.6, 43.7, 43.7, 28.4, 26.2, 25.7, 25.0, 18.9,
18.2; IR (neat ﬁlm NaCl) 3361, 2917, 1667, 1441, 1205 cm−1; HRMS
(MM: ESI-APCI+) m/z calcd for C17H18N2OF3 [M + H]
+ 323.1366,
found 323.1365.
3-(2-Azidoethyl)-3-bromoindolin-2-one (26. A ﬂame-dried
ﬂask (1000 mL) equipped with a Teﬂon stirbar was charged with 3-
(2-azidoethyl)-1H-indole (SI-6)41 (5.03 g, 30.3 mmol, 1.00 equiv), to
which were subsequently added THF (150 mL), t-BuOH (150 mL),
and water (3.75 mL) followed by cooling to −40 °C. A 0 °C solution
of NBS (8.03 g, 45.1 mmol, 1.50 equiv) in THF (450 mL) was then
added via cannula over 30 min, and the resulting solution was allowed
to warm to −10 °C over 2 h. Warming continued slowly over 30 min
to 0 °C. After 20 min at 0 °C, the solvent was removed under reduced
pressure. Puriﬁcation was performed via ﬂash column chromatography
(9:1 → 1:2 pentanes:ether) to aﬀord bromooxindole 26 (5.46 g, 64%
yield) as a yellow solid. 3-(2-azidoethyl)indolin-2-one (SI-7) (1.50 g,
25% yield) was also isolated as a light yellow solid. Bromooxindole 26:
Rf = 0.46 (2:1 hexanes/EtOAc);
1H NMR (300 MHz, CDCl3) δ
1H
NMR (300 MHz, CDCl3) δ 8.12 (br, s, 1H), 7.39 (ddt, J = 7.5, 1.3, 0.6
Hz, 1H), 7.31 (td, J = 7.7, 1.3 Hz, 1H), 7.12 (td, J = 7.6, 1.0 Hz, 1H),
6.93 (d, J = 7.8 Hz, 1H), 3.36 (ddd, J = 12.6, 8.1, 5.2 Hz, 1H), 3.24 (dt,
J = 12.6, 7.6 Hz, 1H), 2.77 (ddd, J = 14.2, 8.1, 7.4 Hz, 1H), 2.60 (ddd,
J = 14.1, 7.8, 5.2 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 180.5, 141.7,
128.4, 128.1, 123.8, 122.3, 110.2, 48.0, 43.3, 29.5; IR (neat ﬁlm NaCl)
3228, 2100, 1693, 1620, 1470 cm−1; HRMS (MM: ESI-APCI+) m/z
calcd for C10H10N4OBr [M + H]
+ 281.0033, found 281.0040.
Oxindole SI-7: Rf = 0.37 (2:1 hexanes/EtOAc);
1H NMR (300
MHz, CDCl3) δ 8.21 (br, s, 1H), 7.23 (d, J = 6.0 Hz, 2H), 7.13 (t, J =
7.5 Hz, 1H), 6.95 (d, J = 8.0 Hz, 1H), 3.41−3.20 (m, 3H), 2.84−2.57
(m, 2H); 13C NMR (75 MHz, CDCl3) δ 176.6, 139.8, 130.6, 129.1,
124.6, 123.5, 111.4, 54.5, 47.6, 38.0; IR (neat ﬁlm NaCl) 3252, 2102,
1732, 1619, 1471 cm−1; HRMS (MM: ESI-APCI+) m/z calcd for
C10H11N4O[M + H]
+ 203.0927, found 203.0933.
3-(2-Azidoethyl)-3-(1-(2-methylprop-1-en-1-yl)-2-(2,2,2-tri-
ﬂuoroacetyl)-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-5-
yl)indolin-2-one (28). A ﬂame-dried vial (20 mL) equipped with a
Teﬂon stirbar was charged with indole 25 (120 mg, 0.372 mmol, 1.00
equiv) and bromooxindole 26 (157 mg, 0.559 mmol, 1.50 equiv),
which were subsequently dissolved in THF (4 mL). Cesium carbonate
(243 mg, 0.746 mmol, 2.00 equiv) was then added. After addition, the
reaction was stirred for 12 h, and then water was added. The resulting
solution was extracted with EtOAc (3 × 3 mL). The combined organic
layers were dried over MgSO4 and concentrated in vacuo. The residue
was puriﬁed by ﬂash column chromatography (9:1 → 2:1 hexanes/
EtOAc) to aﬀord adduct 28 (134 mg, 69% yield) as a yellow foam: Rf
= 0.34 (2:1 hexanes/EtOAc × 2 elutions). (Due to the distinct
presence of rotameric isomers, the 1H NMR and 13C NMR contained
extra peaks. See the attached spectrum, Supporting Information): 1H
NMR (300 MHz, CDCl3) δ 8.35 (s, 1H), 8.26 (s, 2H), 7.41−6.95 (m,
12H), 6.91−6.86 (m, 1H), 6.81−6.74 (m, 1H), 6.09 (d, J = 7.9 Hz,
1H), 5.37 (d, J = 7.9 Hz, 1H), 5.33−5.27 (m, 1H), 4.17 (d, J = 13.8
Hz, 1H), 3.95 (d, J = 15.4 Hz, 1H), 3.81 (t, J = 13.8 Hz, 1H), 3.63 (t, J
= 12.2 Hz, 1H), 3.33−3.05 (m, 5H), 3.05−2.85 (m, 3H), 2.65−2.51
(m, 2H), 1.83 (d, J = 1.4 Hz, 2H), 1.79 (d, J = 1.4 Hz, 2H), 1.73−1.67
(m, 4H), 1.63 (s, 2H); 13C NMR (75 MHz, CDCl3) δ 178.8, 178.7,
157.1, 156.7, 156.5, 156.0, 141.4, 141.3, 138.4, 137.0, 136.0, 135.6,
135.1, 134.4, 130.1, 129.9, 129.8, 129.5, 129.5, 125.5, 125.0, 124.9,
124.8, 124.4, 123.7, 123.3, 122.4, 122.2, 119.5, 119.0, 118.7, 118.1,
114.9, 111.8, 111.5, 111.2, 111.2, 110.1, 109.8, 60.5, 58.3, 52.7, 52.6,
47.3, 47.3, 43.5, 43.4, 35.0, 34.8, 28.1, 26.3, 25.8, 24.5, 19.0, 18.3; IR
(neat ﬁlm NaCl) 3335, 2102, 1713, 1674 cm−1; HRMS (MM: ESI-
APCI+) m/z calcd for C27H26N6O2F3 [M + H]
+ 523.2064, found
523.2058.
4-(3-(2-Azidoethyl)-3-(4a-chloro-1-(2-methylprop-1-en-1-
yl)-2-(2,2,2-triﬂuoroacetyl)-2,3,4,4a-tetrahydro-1H-azepino-
[5,4,3-cd]indol-5-yl)-2-oxoindolin-1-yl)-3-nitrobenzenesulfonic
Acid (29). To a solution of adduct 28 (183 mg, 0.350 mmol, 1.00
equiv) in THF (4 mL) was added sodium hydride (60% dispersion in
mineral oil, 42 mg, 1.05 mmol, 3.00 equiv) at 0 °C. The reaction
mixture was stirred for 5 min, and o-nitrobenzylsulfonyl chloride (116
mg, 0.523 mmol, 1.50 equiv) was added at 0 °C. The reaction was
stirred for 10 min, and then a satdrated solution of ammonium
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chloride was added. The resulting solution was extracted with EtOAc
(3 × 3 mL). The combined organic layers were dried over MgSO4 and
concentrated in vacuo. The residue was puriﬁed by ﬂash column
chromatography (15:1→ 2:1 hexanes/EtOAc) to aﬀord alkyl chloride
29 (142 mg, 73% yield) as a white crystalline solid: Rf = 0.26 (2:1
hexanes/EtOAc). (Due to the distinct presence of rotameric isomers,
the 1H NMR and 13C NMR contained extra peaks. See the attached
spectrum, Supporting Information): 1H NMR (300 MHz, CDCl3) δ
8.64−8.59 (m, 2H), 7.95−7.84 (m, 8H), 7.55−7.47 (m, 6H), 7.37−
7.26 (m, 5H), 7.15 (d, J = 7.0 Hz, 2H), 6.95 (d, J = 8.0 Hz, 1H), 6.31
(d, J = 7.5 Hz, 2H), 5.76−5.72 (m, 2H), 5.61 (d, J = 7.5 Hz, 1H),
4.20−4.08 (m, 2H), 3.94−3.67 (m, 3H), 3.31−3.19 (m, 2H), 2.99−
2.74 (m, 6H), 2.29 (dd, J = 3.0, 10.5 Hz, 1H), 1.75 (s, 6H), 1.65 (s,
6H); 13C NMR (75 MHz, CDCl3) δ 175.9, 175.8, 173.8, 173.6, 156.3,
155.9, 151.7, 151.6, 148.2, 147.9, 141.6, 140.7, 139.9, 139.7, 139.2,
138.2, 137.4, 136.9, 136.4, 136.0, 135.3, 135.2, 132.6, 130.9, 130.8,
130.4, 130.4, 128.3, 126.8, 126.6, 126.4, 126.3, 125.8, 125.4, 125.3,
125.2, 124.9, 121.7, 121.6, 120.6, 119.8, 118.6, 115.4, 115.3, 114.8,
77.7, 77.4, 77.2, 76.8, 75.7, 75.5, 60.1, 57.6, 55.7, 55.6, 46.5, 46.4, 40.0,
39.1, 37.8, 37.6, 36.1, 32.6, 26.5, 26.0, 18.6, 18.1; IR (neat ﬁlm NaCl)
2102, 1755, 1686, 1544, 1146 cm−1; HRMS (MM: ESI-APCI+) m/z
calcd for C33H28O7N7F3SCl [M + H]
+ 758.1406, found 758.1442.
4-((2-(3-(1-(2-Methylprop-1-en-1-yl)-6-(2-nitro-4-sulfophen-
yl)-2-(2,2,2-triﬂuoroacetyl)-2,3,4,6-tetrahydro-1H-azepino-
[5,4,3-cd]indol-8-yl)-2-oxopyrrolidin-3-yl)phenyl)amino)-3-ni-
trobenzenesulfonic Acid (32). A ﬂame-dried ﬂask (100 mL)
equipped with a Teﬂon stirbar was charged with indole 25 (1.03 g,
3.21 mmol, 1.00 equiv) and bromooxindole 26 (2.25 mg, 8.02 mmol,
2.50 equiv), which were subsequently dissolved in dichloromethane
(32 mL). Cesium carbonate (3.14 g, 9.62 mmol, 3.00 equiv) was then
added. After addition, the reaction was stirred for 3 h, and then water
was added. The resulting solution was extracted with EtOAc (3 × 20
mL). The combined organic layers were dried over MgSO4 and
concentrated in vacuo. The residue was puriﬁed by ﬂash column
chromatography (18:1 → 1:2 hexanes/EtOAc) to aﬀord adduct 28
(404 mg, 24% yield), adduct 30 (538 mg, 32% yield), and adduct 31
(548 mg, 24% yield). Adduct 30: Rf = 0.18 (2:1 hexanes/EtOAc × 2
elutions). (Due to the distinct presence of rotameric isomers, the 1H
NMR and 13C NMR contained extra peaks. See the attached spectrum,
Supporting Information): 1H NMR (300 MHz, CDCl3) δ 8.91 (d, J =
13.0 Hz, 2H), 8.33 (d, J = 6.0 Hz, 2H), 7.28−7.03 (m, 8H), 6.95−6.86
(m, 6H), 6.75 (d, J = 7.5 Hz, 1H), 6.11 (d, J = 7.5 Hz, 1H), 5.31 (dd, J
= 7.5, 29.5 Hz, 2H), 4.30 (d, J = 13.5 Hz, 1H), 4.06−4.01 (m, 1H),
3.94−3.84 (m, 1H), 3.71 (t, J = 13.0 Hz, 1H), 3.29 (t, J = 13.0 Hz,
1H), 3.17−3.13 (m, 6H), 2.98 (d, J = 16.5 Hz, 1H), 2.89−2.75 (m,
2H), 2.53−2.44 (m, 2H), 1.75−1.69 (m, 10H); 13C NMR (75 MHz,
CDCl3) δ 181.1, 180.9, 157.4, 157.0, 156.7, 156.2, 141.1, 138.5, 137.5,
137.3, 137.1, 135.5, 134.8, 133.4, 133.2, 132.2, 132.1, 128.8, 128.7,
125.1, 124.0, 123.6, 123.2, 123.1, 122.8, 122.5, 119.0, 118.7, 117.0,
115.7, 115.1, 114.9, 113.3, 112.6, 110.7, 108.6, 108.5, 60.6, 58.6, 55.5,
55.4, 47.9, 43.8, 43.7, 36.6, 36.3, 28.4, 26.3, 25.8, 25.0, 18.9, 18.3; IR
(neat ﬁlm NaCl) 3328, 2100, 1712, 1682 cm−1. Adduct 31: Rf = 0.09
(2:1 hexanes/EtOAc tmex 2 elutions); (Due to the distinct presence
of rotameric isomers, the 1H NMR and 13C NMR contained extra
peaks. See the attached spectrum, Supporting Information): 1H NMR
(300 MHz, acetone-d6) δ 10.43 (d, J = 11.7 Hz, 1H), 9.80 (d, J = 7.9
Hz, 1H), 9.59 (d, J = 4.9 Hz, 1H), 7.43−7.17 (m, 7H), 7.14−6.92 (m,
6H), 6.67 (dd, J = 18.0, 8.0 Hz, 1H), 6.11 (d, J = 8.1 Hz, 1H), 5.50−
5.25 (m, 2H), 4.07−3.48 (m, 4H), 3.34−3.12 (m, 5H), 3.04 (s, 3H),
2.96−2.38 (m, 8H), 1.84−1.58 (m, 7H); 13C NMR (75 MHz, acetone-
d6) δ 180.2, 180.1, 177.9, 177.8, 143.1, 143.0, 142.9, 138.3, 137.4,
137.2, 136.8, 135.3, 134.8, 134.6, 134.4, 133.6, 133.3, 133.2, 133.0,
131.3, 129.9, 129.3, 129.2, 126.1, 125.3, 125.2, 125.0, 124.8, 123.9,
123.6, 122.9, 118.0, 147.1, 111.0, 110.9, 110.3, 109.9, 109.4, 109.2,
61.2, 59.2, 55.8, 55.7, 52.7, 52.7, 48.6, 47.6, 44.0, 37.0, 36.9, 35.4, 28.2,
26.1, 25.7, 24.8, 18.8, 18.3; IR (neat ﬁlm NaCl) 3305, 2101, 1713,
1472 cm−1; HRMS (MM: ESI-APCI+) m/z calcd for C37H34N10F3O3
[M + H]+ 723.2762, found 723.2761.
A ﬂame-dried vial (4 mL) equipped with a Teﬂon stirbar was
charged with adduct 30 (43.7 mg, 0.0836 mmol, 1.00 equiv), which
was subsequently dissolved in THF (800 μL). The solution was cooled
to 0 °C, and then sodium hydride (60% dispersion in mineral oil, 17
mg, 0.425 mmol, 5.00 equiv) was added. Five minutes after the sodium
hydride addition, o-nitrobenzylsulfonyl chloride (93 mg, 0.420 mmol,
5.02 equiv) was added. The reaction was stirred for 10 min, and then a
satdrated solution of ammonium chloride was added. The resulting
solution was extracted 3 times with ether, the organic layers were
combined and dried over magnesium sulfate, and the solvent was
removed under reduced pressure. Puriﬁcation was performed via ﬂash
column chromatography (9:1 →1:1 hexanes/EtOAc) to aﬀord the 4-
((R)-8-((R)-3-(2-azidoethyl)-1-(2-nitro-4-sulfophenyl)-2-oxoindolin-
3-yl)-1-(2-methylprop-1-en-1-yl)-2-(2,2,2-triﬂuoroacetyl)-1,2,3,4-tetra-
hydro-6H-azepino[5,4,3-cd]indol-6-yl)-3-nitrobenzenesulfonic acid
(SI-8) (49.0 mg, 66% yield) as a yellow solid. Rf = 0.42 (1:1
hexanes/EtOAc). (Due to the distinct presence of rotameric isomers,
the 1H NMR and 13C NMR contained extra peaks. See the attached
spectrum, Supporting Information): 1H NMR (300 MHz, CDCl3) δ
8.54−8.51 (m, 2H), 8.03−8.00 (m, 2H), 7.88−7.56 (m, 16H), 7.50 (s,
1H), 7.42−7.35 (m, 5H), 7.18−7.12 (m, 3H), 6.95 (s, 1H), 6.61 (d, J
= 7.5 Hz, 1H), 5.97 (d, J = 7.5 Hz, 1H), 5.23−5.16 (m, 2H), 4.27 (d, J
= 13.5 Hz, 1H), 4.02 (d, J = 15.0 Hz, 1H), 3.89−3.79 (m, 1H), 3.64 (t,
J = 11.0 Hz, 1H), 3.32−2.80 (m, 11H), 2.48−2.33 (m, 2H), 1.73 (s,
12H); 13C NMR (75 MHz, CDCl3) δ 176.2, 176.0, 157.3, 156.9,
156.5, 148.0, 148.0, 140.2, 140.1, 140.0, 138.6, 137.2, 136.6, 136.2,
136.0, 135.7, 135.5, 134.8, 134.7, 132.8, 132.8, 132.4, 131.2, 131.2,
131.1, 130.9, 130.6, 129.9, 129.8, 129.5, 129.2, 127.4, 127.0, 125.7,
125.7, 125.4, 125.4, 125.2, 125.1, 124.9, 122.8, 121.9, 121.1, 120.0,
118.8, 118.5, 117.9, 115.5, 114.9, 110.6, 60.2, 58.1, 55.0, 55.0, 47.5,
42.8, 42.7, 36.6, 36.6, 39.9, 28.0, 26.3, 25.8, 25.0, 18.9, 18.3; IR (neat
ﬁlm NaCl) 2930, 2101, 1754, 1684, 1544 cm−1.
To a solution of nosylate SI-8 (43.1 mg, 0.0483 mmol, 1.00 equiv)
in THF (1 mL) and water (250 μL) was added triphenylphosphine
(25 mg, 0.0953 mmol, 2.00 equiv). The reaction was stirred for 3 h at
50 °C, and then the solvent was removed under reduced pressure. The
residue was puriﬁed by ﬂash column chromatography (3:1 → 1:1
hexanes/EtOAc) to aﬀord the lactam 32 (49.0 mg, 66% yield) as a
yellow crystalline solid: Rf = 0.14 (1:1 hexanes/EtOAc). (Due to the
distinct presence of rotameric isomers, the 1H NMR and 13C NMR
contained extra peaks. See the attached spectrum, Supporting
Information): 1H NMR (300 MHz, CDCl3) δ 10.82 (s, 2H), 7.75−
7.50 (m, 17H), 7.41 (td, J = 7.8, 1.4 Hz, 2H), 7.36−7.23 (m, 9H), 7.13
(dd, J = 7.5, 1.9 Hz, 1H), 6.80 (dd, J = 6.8, 1.6 Hz, 2H), 6.54 (d, J =
7.6 Hz, 1H), 5.99 (d, J = 7.7 Hz, 1H), 5.34−5.16 (m, 2H), 4.26 (d, J =
13.4 Hz, 1H), 4.00 (d, J = 15.6 Hz, 1H), 3.80 (dd, J = 14.3, 10.2 Hz,
1H), 3.68−3.48 (m, 3H), 3.32−2.97 (m, 9H), 2.29 (q, J = 7.8, 6.7 Hz,
2H), 1.66 (d, J = 1.3 Hz, 6H), 1.60 (s, 6H); 13C NMR (75 MHz,
CDCl3) δ 180.0, 157.3, 156.8, 156.7, 156.2, 147.9, 147.8, 147.7, 139.5,
139.4, 137.8, 137.5, 137.4, 136.9, 136.5, 136.4, 136.2, 136.1, 135.6,
135.3, 135.1, 133.6, 132.9, 132.5, 132.2, 132.0, 131.0, 130.9, 130.5,
129.0, 127.9, 127.8, 126.3, 126.2, 125.2, 125.1, 125.0, 124.9, 124.8,
124.5, 124.4, 124.3, 123.3, 122.4, 121.4, 120.5, 119.2, 118.9, 118.5,
118.4, 115.1, 110.2, 109.7, 77.7, 77.4, 77.2, 76.8, 60.1, 58.2, 57.7, 43.0,
42.8, 39.8, 38.8, 28.5, 26.1, 25.7, 25.3, 18.9, 18.3; IR (neat ﬁlm NaCl)
3098, 2916, 1682, 1545, 1368, 1170, 732 cm−1; HRMS (MM: ESI-
APCI+) m/z calcd for C39H34N6O10F3S2 [M + H]
+ 867.1729, found
867.1735.
4a-Bromo-2-tosyl-1,2,3,4,4a,6-hexahydro-5H-azepino[5,4,3-
cd]indol-5-one (35). To a solution of 2,3,4,6-tetrahydro-1H-
azepino[5,4,3-cd]indole (SI-9) (106 mg, 0.614 mmol, 1.00 equiv)
and Et3N (0.17 mL, 1.23 mmol, 2.00 equiv) in CH2Cl2 (4 mL) cooled
to 0 °C was added a solution of TsCl (117 mg, 0.614 mmol, 1.00
equiv) in CH2Cl2 (3 mL) dropwise. The ice bath was removed, and
the reaction mixture was stirred for 5 h, diluted with EtOAc (160 mL),
and washed with 0.5 N HCl (2 × 30 mL) and brine. The organic
layers were combined, dried over MgSO4, and concentrated in vacuo.
The residue was puriﬁed by column chromatography (2:1 hexanes/
EtOAc) to aﬀord 2-tosyl-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]-
indole (SI-10) (164 mg, 82% yield).
Indole SI-10 was dissolved in THF (10 mL), t-BuOH (10 mL), and
water (1 mL). The solution was cooled to 0 °C, and pyridinium
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tribromide (504 mg, 1.54 mmol, 1.02 equiv) was added. The reaction
mixture was stirred at 0 °C for 45 min and then allowed to warm to
ambient temperature. The reaction was quenched by addition of 10
mL of 1:1 v/v 1 M Na2S2O3/satd NaHCO3. The reaction mixture was
diluted with brine (50 mL) and extracted with EtOAc (3 × 50 mL).
The combined organic extracts were dried with MgSO4 and
concentrated in vacuo. The residue was puriﬁed by silica gel
chromatography (2:1 hexanes/acetone) to aﬀord 2-tosyl-1,2,3,4,4a,6-
hexahydro-5H-azepino[5,4,3-cd]indol-5-one (SI-11) (397 mg, 75%
yield) as a white solid: Rf = 0.15 (1:1 hexanes/EtOAc);
1H NMR (300
MHz, CDCl3) δ 8.77 (br, s, 1H), 7.56 (d, J = 8.2 Hz, 2H), 7.21−7.14
(m, 3H), 6.94 (d, J = 7.7 Hz, 1H), 6.80 (d, J = 7.7 Hz, 1H), 4.80 (d, J
= 15.5 Hz, 1H), 4.30 (d, J = 13.6 Hz, 1H), 4.15 (d, J = 15.5 Hz, 1H),
3.52 (dd, J = 12.5, 3.5 Hz, 1H), 3.24 (t, J = 12.6 Hz, 1H), 2.38 (s, 3H),
2.30 (m, 1H), 1.53 (m, 1H); 13C (75 MHz, CDCl3) δ 178.4, 143.3,
140.5, 137.1, 135.9, 129.6, 128.4, 128.3, 127.0, 121.5, 109.1, 53.3, 51.6,
46.2, 28.6, 21.5; IR (neat ﬁlm NaCl) 3276, 2925, 2853, 1698, 1618,
1463, 1326, 1153 cm−1; HRMS (MM: ESI-APCI+) m/z calcd for
C18H19N2O3S [M + H]
+ 343.1111, found 343.1104.
LiHMDS (429 mg, 2.57 mmol, 2.50 equiv) was dissolved in THF
(5 mL). The solution was cooled to −78 °C, and a solution of
oxindole SI-11 (352 mg, 1.03 mmol, 1.00 equiv) in THF (20 mL) was
added dropwise over 20 min. The reaction mixture was stirred at −78
°C for 20 min and transferred to a precooled solution of N-
bromosuccinimide (457 mg, 2.57 mmol, 2.50 equiv) in THF (10 mL)
that was protected from light. The resulting reaction mixture was
placed in a −40 °C bath for 1 h, while being protected from light, and
then quenched with satd NH4Cl. The reaction mixture was allowed to
warm to ambient temperature, diluted with brine (100 mL), and
extracted with EtOAc (3 × 70 mL). The combined organic extracts
were dried over MgSO4 and concentrated to aﬀord a yellow oil, which
was puriﬁed by silica gel chromatography (2:1 hexanes/EtOAc) to
aﬀord bromooxindole 35 (334 mg, 76% yield) as a yellow solid: Rf =
0.40 (1:1 hexane/EtOAc); 1H NMR (300 MHz, CDCl3) δ 8.49 (br, s,
1H), 7.58 (d, J = 8.2 Hz, 2H), 7.24−7.19 (m, 3H), 6.96 (d, J = 7.7 Hz,
1H), 6.83 (d, J = 7.8 Hz, 1H), 4.76 (d, J = 15.4 Hz, 1H), 4.32 (m, 2H),
3.80 (t, J = 13.2 Hz, 1H), 2.39 (s, 3H), 2.33 (m, 1H), 1.90 (m, 1H);
13C NMR (75 MHz, CDCl3) δ 175.1, 143.5, 139.0, 137.7, 136.9, 130.7,
129.7, 128.7, 126.9, 122.6, 110.1, 59.2, 51.6, 48.3, 35.2, 21.5; IR (neat
ﬁlm NaCl) 3313, 2930, 1734, 1615, 1460, 1334, 1155, 1096, 727 cm−1;
HRMS (MM: ESI-APCI+) m/z calcd for C18H18BrN2O3S [M + H]
+
421.0216, found 421.0213.
2-(2-Nitrophenyl)-2-(5-oxo-2-tosyl-1,2,3,4,5,6-hexahydro-
4aH-azepino[5,4,3-cd]indol-4a-yl)acetonitrile (37). A solution of
bromooxindole 35 (44.9 mg, 0.107 mmol, 1.00 equiv) and 2-
nitrophenylacetonitrile 36 (34.6 mg, 0.213 mmol, 2.00 equiv) in THF
(3 mL) was cooled to −78 °C. DBU (64 mL, 0.426 mmol, 4.00 equiv)
was added dropwise. The reaction mixture was then allowed to
gradually warm to ambient temperature. After 8 h, the reaction mixture
was quenched with satd NH4Cl (10 mL) and the mixture was
extracted with EtOAc (4 × 5 mL). The combined organic extracts
were dried over MgSO4 and concentrated under reduced pressure to
aﬀord a brown oil, which was puriﬁed by preparatory thin-layer
chromatography on silica gel (1:1 hexane/EtOAc x2 elutions) to aﬀord
nitrile 37 (34.8 mg, 64% yield) as an orange-yellow solid: Rf = 0.28
(1:1 hexane/EtOAc); 1H NMR (300 MHz, CDCl3) δ7.92 (m, 1H),
7.63 (m, 2H), 7.55 (m, 2H), 7.43 (m, 1H), 7.29 (d, J = 8.0 H, 2H),
7.18 (t, J = 7.8 Hz, 1H), 6.97 (d, J = 7.7 Hz, 1H), 6.48 (d, J = 7.4 Hz,
1H), 6.07 (s, 1H), 4.80 (d, J = 16.2 Hz, 1H), 4.29 (m, 2H), 3.45 (app.
t, J = 13.2 Hz, 1H), 2.74 (app. dd, J = 15.0, 2.6 Hz, 1H), 2.43 (s, 3H),
1.94 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 176.2, 147.9, 143.8,
140.3, 137.9, 136.5, 133.5, 132.5, 131.0, 130.3, 130.0, 127.0, 124.8,
124.5, 124.5, 123.7, 116.2, 109.4, 54.4, 52.6, 46.8, 34.2, 32.1, 21.6; IR
(neat ﬁlm NaCl) 3302, 2920, 1724, 1527, 1155, 724 cm−1; HRMS
(MM: ESI-APCI+) m/z calcd for C26H23N4O5S [M + H]
+ 503.1384,
found 503.1411.
Dimethyl 2-(2-Nitrophenyl)-2-(5-oxo-2-tosyl-1,2,3,4,5,6-hex-
ahydro-4aH-azepino[5,4,3-cd]indol-4a-yl)malonate (39). To a
solution of bromooxindole 35 (50.0 mg, 0.119 mmol, 1.00 equiv) and
malonate 38 (90.1 mg, 0.356 mmol, 3.00 equiv) in THF (0.6 mL) was
added DBU (54.2 mg, 0.356 mmol, 3.00 equiv) at −78 °C. The
reaction solution was slowly warmed to 23 °C. The reaction solution
was stirred for 12 h and quenched with satd NH4Cl. The mixture was
extracted with EtOAc (3 × 1 mL) and brine. The combined organic
extracts were dried over MgSO4 and concentrated under reduced
pressure, and then the residue was puriﬁed by preparatory thin-layer
chromatography on silica gel (1:1 hexane/EtOAc) to aﬀord nitrile 39
(23 mg, 32% yield): Rf = 0.15 (1:1 hexanes/EtOAc);
1H NMR (300
MHz, CDCl3) δ 8.85 (br, s, 1H), 8.23 (dd, J = 8.0, 1.5 Hz, 1H), 7.58−
7.51 (m, 5H), 7.24 (d, J = 8.0 Hz, 2H), 6.96 (dd, J = 7.5, 1.5 Hz, 1H),
6.76 (d, J = 1.5 Hz, 1H), 6.66 (d, J = 1.0 Hz, 1H), 4.44 (d, J = 15.4 Hz,
1H), 4.15 (d, J = 15.4 Hz, 1H), 3.95 (d, J = 14.6 Hz, 1H), 3.82 (s, 3H),
3.75 (s, 3H), 3.69 (m, 1H), 2.40 (s, 3H), 1.95 (d, J = 14.6 Hz, 1H),
1.66 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 179.1, 168.8, 148.1,
143.4, 141.2, 138.7, 137.0, 134.7, 133.9, 132.0, 129.7, 129.1, 128.3,
126.8, 125.7, 122.8, 110.7, 74.8, 68.7, 53.7, 53.5, 51.3, 46.0, 33.4, 21.5;
IR (neat ﬁlm NaCl) 3313, 1737, 1623, 1530, 1450, 1347, 1241, 1153,
1091, 895, 729 cm−1; HRMS (FAB) m/z calcd for C29H26N3O9S [M −
H]− 592.1395, found 592.1382.
4a-Bromo-1-(2-methylprop-1-en-1-yl)-2-tosyl-1,2,3,4,4a,6-
hexahydro-5H-azepino[5,4,3-cd]indol-5-one (40). To a solution
of aurantioclavine 4 (300 mg, 0.00133 mol, 1.00 equiv) and Et3N (0.37
mL, 0.00265 mol, 2.00 equiv) in CH2Cl2 (4 mL) cooled to 0 °C was
added a solution of TsCl (254 mg, 0.00133 mmol, 1.00 equiv) in
CH2Cl2 (3 mL) dropwise. The ice bath was removed, and the reaction
mixture was stirred for 5 h, then diluted with EtOAc (200 mL) and
washed with 0.5 N HCl (2 × 35 mL) and brine. The organic layers
were combined, dried over MgSO4 and concentrated in vacuo. The
residue was puriﬁed by column chromatography (2:1 hexanes/EtOAc)
to aﬀord 1-(2-methylprop-1-en-1-yl)-2-tosyl-2,3,4,6-tetrahydro-1H-
azepino[5,4,3-cd]indole (SI-12) (405 mg, 80% yield).
A solution of indole SI-12 (902.2 mg, 2.371 mmol, 1.00 equiv) in
THF/t-BuOH/H2O (10:10:1 v/v/v, 52.5 mL) was cooled to 0 °C,
and pyridinium tribromide (834.2 mg, 2.608 mmol, 1.10 equiv) was
added in small portions over 5 min. The reaction mixture was stirred at
0 °C for 15 min, and then allowed to warm to ambient temperature.
After 5 min at ambient temperature, the reaction mixture was
quenched by addition of 1:1 v/v satd NaHCO3/1 M aq Na2S2O3 (15
mL), poured into brine (150 mL), and extracted with EtOAc (3 × 100
mL). The combined extracts were dried over Na2SO4 and
concentrated under reduced pressure to aﬀord a brown solid, which
was puriﬁed by silica gel chromatography (2:1→ 1:1 hexanes/EtOAc)
to aﬀord 1-(2-methylprop-1-en-1-yl)-2-tosyl-1,2,3,4,4a,6-hexahydro-
5H-azepino[5,4,3-cd]indol-5-one (SI-13) (747.5 mg, 80% yield): Rf
= 0.22 (5:1 benzene/MeCN); 1H NMR (300 MHz, CDCl3) δ 8.12
(br, s, 1H), 7.33 (dd, J = 8.5, 2.1 Hz, 2H), 7.03 (m, 1H), 6.96 (d, J =
7.2 Hz, 2H), 6.82 (d, J = 7.7 Hz, 1H), 6.64 (d, J = 8.0 Hz, 1H), 5.76
(d, J = 8.0 Hz, 1H), 5.31 (m, 1H), 4.00 (dt, J = 15.7, 2.8 Hz, 1H),
3.64−3.50 (m, 2H), 2.22 (s, 3H), 2.00 (m, 1H), 1.67 (s, 3H), 1.65 (s,
3H), 1.25 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 178.4, 142.9,
140.9, 140.5, 138.2, 129.2, 128.3, 128.3, 127.0, 126.7, 121.3, 119.0,
108.7, 59.0, 46.0, 43.8, 27.8, 26.0, 21.4, 18.5; IR (neat ﬁlm NaCl) 3246,
2925, 1713, 1615, 1460, 1326, 1155, 732 cm−1; HRMS (MM: ESI-
APCI+) m/z calcd for C22H25N2O3S [M + H]
+ 397.1580, found
397.1586.
A solution of oxindole SI-13 (172.0 mg, 0.434 mmol, 1.00 equiv) in
THF (5 mL) was added dropwise to a freshly prepared solution of
LiHMDS (217.8 mg, 1.301 mmol, 3.00 equiv) in THF (5 mL) that
had been precooled to −78 °C. After 20 min at −78 °C, the resulting
solution was transferred via cannula to a solution of N-
bromosuccinimide (231.6 mg, 1.301 mmol, 3.00 equiv) in THF (5
mL) that had been precooled to −78 °C. The resulting yellow reaction
mixture was allowed to warm to −15 °C (the reaction ﬂask was
transferred to a bath composed of ethylene glycol and dry ice) and
maintained at this temperature for 2 h. The reaction mixture was then
cooled to −78 °C and quenched by addition of satd NH4Cl (5 mL).
The yellow reaction mixture was allowed to warm to ambient
temperature and diluted with H2O (80 mL), then extracted with
EtOAc (3 × 70 mL). The combined organic extracts were washed with
brine (100 mL), dried over MgSO4, and concentrated under reduced
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pressure to aﬀord a yellow oil, which was puriﬁed immediately by silica
gel chromatography (2:1 hexanes/EtOAc) to aﬀord a 3:1 mixture of
bromooxindole 40 (>20:1 dr) and dehydrobromination product, 1-(2-
methylprop-1-en-1-yl)-2-tosyl-1,2,3,6-tetrahydro-5H-azepino[5,4,3-
cd]indol-5-one (SI-14) (131.1 mg, 64% combined yield, 50% yield of
bromooxindole 40). Bromooxindole 40 was stored frozen in benzene
and used without further puriﬁcation. The relative conﬁguration of this
bromooxindole was assigned based on the stereochemistry of the
malonate adduct obtained (see below). Quenching the reaction prior
to completion aﬀorded the bromooxindole 40 as a single diastereomer,
which showed greater stability, and could be fully characterized: Rf =
0.50 (1:1 hexane/EtOAc); 1H NMR (300 MHz, CDCl3) δ 8.62 (br, s,
1H), 7.49 (d, J = 8.0 Hz, 2H), 7.21 (t, J = 8.0, 1H), 7.13 (d, J = 8.0 Hz,
2H), 6.90 (d, J = 7.5 Hz, 1H), 6.79 (dd, J = 8.0, 1.0 Hz, 1H), 5.96 (td,
J = 8.5, 1.5 Hz, 1H), 5.88 (d, J = 8.5 Hz, 1H), 4.18−4.02 (m, 2H), 2.35
(s, 3H), 2.27 (m, 1H), 1.97 (m, 1H), 1.76 (d, J = 1.0 Hz, 3H), 1.75 (d,
J = 1.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 174.8, 143.2, 142.4,
140.2, 139.2, 137.8, 130.8, 129.4, 126.9, 126.1, 122.7, 120.1, 109.7,
66.8, 59.5, 39.8, 34.4, 26.1, 21.4, 18.4; IR (neat ﬁlm NaCl) 3291, 1734,
1617, 1602, 1457, 1326, 1156, 1092, 738 cm−1; HRMS (MM: ESI-
APCI+) m/z calcd for C22H24BrN2O3S [M + H]
+ 475.0686, found
475.0668.
Dimethyl 2-(1-(2-Methylprop-1-en-1-yl)-5-oxo-2-tosyl-
1,2,3,4,5,6-hexahydro-4aH-azepino[5,4,3-cd]indol-4a-yl)-
malonate (42). Bromooxindole 40 (>20:1 dr, 51.3 mg, 0.108 mmol,
1.00 equiv) was dissolved in THF (2 mL). Dimethyl malonate 41 (37
mL, 0.324 mmol, 3.00 equiv) was added, and the reaction mixture was
cooled to −78 °C. DBU (48 mL, 0.324 mmol, 3.00 equiv) was added
dropwise. The reaction mixture was stirred at −78 °C for 15 min and
then warmed to 23 °C. After the reaction mixture was maintained at
23 °C for 6 h, satd NH4Cl (2 mL) was added and the mixture was
warmed to ambient temperature. The reaction mixture was diluted
with EtOAc (50 mL) and satd NH4Cl (50 mL). The phases were
separated, and the aqueous phase was extracted with EtOAc (2 × 50
mL). The combined organic extracts were dried over Na2SO4 and
concentrated to aﬀord colorless oil. Analysis of the crude oil by 1H
NMR indicated >20:1 dr of the malonate adduct 42. The residue was
puriﬁed by silica gel chromatography (1:1 hexane/EtOAc) to aﬀord
malonate 42 (42 mg, 74% yield): Rf = 0.20 (1:1 hexane/EtOAc);
1H
NMR (300 MHz, CDCl3) δ 7.88 (br, s, 1H), 7.26 (d, J = 8.0 Hz, 2H),
7.14 (t, J = 7.5 Hz, 1H), 7.00 (d, J = 8.0 Hz, 2H), 6.91, (d, J = 7.5 Hz,
1H), 6.72 (d, J = 8.0 Hz, 1H), 5.92 (d, J = 4.5 Hz, 1H), 5.38 (d, J = 4.5
Hz, 1H), 4.62 (s, 1H), 4.06 (m, 1H), 3.89 (m, 1H), 3.78 (s, 3H), 3.46
(s, 3H), 2.40 (m, 1H), 2.30 (s, 3H), 1.82 (s, 3H), 1.79 (s, 3H), 1.07
(m, 1H); 13C NMR (75 MHz, CDCl3) δ 177.8, 166.8, 166.8, 143.0,
141.9, 141.4, 141.0, 137.9, 129.2, 128.9, 127.6, 127.0, 123.0, 124.0,
109.0, 59.6, 53.9, 52.9, 52.3, 51.3, 39.8, 28.9, 26.4, 21.4, 18.6; IR (neat
ﬁlm NaCl) 3338, 2953, 1733, 1618, 1597, 1458, 1327, 1158 cm−1;
HRMS (MM: ESI-APCI+) m/z calcd for C27H31N2O7S [M + H]
+
527.1846, found 527.1848.
Diallyl 2-(2-Nitrophenyl)-2-(2-oxo-3-(2-((triisopropylsilyl)-
oxy)ethyl)indolin-3-yl)malonate (46). To a suspension of
Cs2CO3 (5.37 g, 16.5 mmol, 3.00 equiv) and bromooxindole 43
(2.27 g, 5.50 mmol, 1.00 equiv) in THF (100 mL) was added
malonate 44 (5.04 g, 16.5 mmol, 3.00 equiv) at 0 °C. The reaction
mixture was then allowed to slowly warm to 23 °C and stirred for 16 h.
Solids were removed via ﬁltration through a Celite plug (rinsed with
EtOAc), and the resulting purple solution was concentrated under
reduced pressure. The residue was puriﬁed by column chromatog-
raphy using a Teledyne Isco CombiFlash (SiO2, 120 g column, 100:0
→ 3:1 hexanes/EtOAc) to provide alkylation product 46 (8.9 g, 85%
yield) as a colorless oil: Rf = 0.18 (3:1 hexanes/EtOAc);
1H NMR
(500 MHz, CDCl3) δ 7.97 (d, J = 8.0 Hz, 1H), 7.94 (s, 1H), 7.73 (dd,
J = 7.9, 1.6 Hz, 1H), 7.41 (dt, J = 8.0, 1.6 Hz, 1H), 7.38−7.33 (m, 2H),
7.13 (dt, J = 7.7, 1.1 Hz, 1H), 6.89 (dt, J = 7.7, 1.0 Hz, 1H), 6.72 (d, J
= 7.6 Hz, 1H), 5.88−5.73 (m, 2H), 5.25 (ddd, J = 17.2, 2.8, 1.4 Hz,
1H), 5.19−5.11 (m, 3H), 4.69 (tdd, J = 13.3, 5.7, 1.4 Hz, 1H), 4.64
(tdd, J = 13.3, 5.7, 1.3 Hz, 1H), 4.57 (tdd, J = 13.4, 5.9, 1.4 Hz, 1H),
4.48 (tdd, J = 13.1, 5.9, 1.1 Hz, 1H), 3.35 (ddd, J = 9.5, 8.5, 6.9 Hz,
1H), 3.07 (dt, J = 9.5, 4.5 Hz, 1H), 2.95 (ddd, J = 12.9, 8.7, 7.0 Hz,
1H), 2.63 (ddd, J = 12.9, 8.5, 4.5 Hz, 1H), 0.97−0.77 (m, 21H); 13C
NMR (125 MHz, CDCl3) δ 177.8, 166.7, 166.3, 150.2, 140.7, 132.4,
131.3, 131.0, 130.8, 129.5, 129.2, 128.5, 126.9, 125.3, 122.4, 119.2,
118.4, 109.1, 66.8, 66.7, 59.5, 56.7, 38.3, 17.8, 11.8; IR (neat ﬁlm
NaCl) 3332, 2942, 1714, 1649, 1618, 1538, 1471, 1356, 1230, 1114,
995, 933, 885, 850, 752, 683 cm−1; HRMS (MM: ESI-APCI+) m/z
calcd for C34H45N2O8Si [M + H]
+ 637.2940, found 637.2945.
Diallyl 2-(1-Methyl-2-oxo-3-(2-((triisopropylsilyl)oxy)ethyl)-
indolin-3-yl)-2-(2-nitrophenyl)malonate (48). To a suspension
of oxindole 46 (0.50 g, 0.79 mmol, 1.00 equiv) and Cs2CO3 (0.77 g,
2.37 mmol, 3.00 equiv) in THF (4.0 mL) was added methyl iodide
(0.3 mL, 4.7 mmol, 6.00 equiv) at 0 °C. The reaction mixture was
stirred for 12 h at 23 °C. After the reaction was complete, satd NH4Cl
was added. The aqueous phase was extracted with EtOAc (3 × 3 mL).
The combined organic phases were washed with brine, dried over
MgSO4, and concentrated in vacuo. The residue was puriﬁed by ﬂash
column chromatography on silica gel (3:1 hexanes/EtOAc) to give
methylated oxindole 48 (0.51g, 99% yield): Rf = 0.33 (3:1 hexanes/
EtOAc); 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 8.0 Hz, 1H), 7.54
(dd, J = 7.9, 1.5 Hz, 1H), 7.42 (d, J = 7.6 Hz, 1H), 7.31 (dt, J = 7.7, 1.6
Hz, 1H), 7.25 (dt, J = 7.8, 1.2 Hz, 1H), 7.10 (dt, J = 7.7, 0.9 Hz, 1H),
6.85 (dt, J = 7.8, 0.8 Hz, 1H), 6.57 (d, J = 7.7 Hz, 1H), 5.80 (tdd, J =
16.3, 10.7, 5.8 Hz, 1H), 5.71 (tdd, J = 16.4, 10.5, 5.9 Hz, 1H), 5.22−
5.02 (m, 4H), 4.69−4.56 (m, 2H), 4.52 (tdd, J = 13.1, 5.8, 1.3 Hz,
1H), 4.36 (tdd, J = 13.3, 5.9, 1.3 Hz, 1H), 3.15−3.02 (m, 4H), 2.96
(ddd, J = 9.7, 8.3, 4.7 Hz, 1H), 2.85 (td, J = 13.2, 7.4 Hz, 1H), 2.67
(ddd, J = 12.8, 8.0, 4.7 Hz, 1H), 0.86−0.71 (m, 21H); 13C NMR (125
MHz, CDCl3) δ 176.3, 166.5, 166.5, 150.3, 143.6, 132.7, 131.3, 130.9,
130.3, 128.8, 128.5, 128.5, 128.3, 126.9, 125.1, 122.3, 119.1, 118.5,
107.3, 66.7, 66.7, 59.6, 56.8, 37.9, 26.1, 17.8, 11.7; IR (neat ﬁlm NaCl)
3421, 3054, 2944, 2866, 1723, 1613, 1539, 1473, 1356, 1253, 1180,
1104, 1068, 935, 862, 840, 752, 690 cm−1; HRMS (MM: ESI-APCI+)
m/z calcd for C35H47N2O8Si [M + H]
+ 651.3096, found 651.3092.
Allyl 1-Methyl-3′-(2-nitrophenyl)-2,2′-dioxo-2′,3′,5′,6′-
tetrahydrospiro[indoline-3,4′-pyran]-3′-carboxylate (50). Ace-
tyl chloride (46.0 μL, 650 μmol, 10.0 equiv) was added to MeOH (1.0
mL) and cooled to 0 °C. The resulting mixture was stirred for 30 min,
and then the solution of oxindole 48 (21.0 mg, 32.0 μmol, 1.00 equiv)
in MeOH (2.0 mL) was added. The reaction was stirred for 2 h at 23
°C and then heated to 65 °C. The reaction mixture was stirred for 16 h
at that temperature. The colorless solution was cooled to ambient
temperature, concentrated under reduced pressure, and subjected to
column chromatography (4:1 hexanes/EtOAc) to aﬀord the desired
lactone 50 (12 mg, 85% yield) as a colorless solid: Rf = 0.29 (50%
EtOAc in hexanes); 1H NMR (400 MHz, CDCl3) δ 7.80 (d, J = 7.4
Hz, 1H), 7.39−7.31 (m, 3H), 7.23−7.15 (m, 2H), 6.82−6.75 (m, 2H),
5.92 (tdd, J = 17.1, 10.6, 5.8 Hz, 1H), 5.30 (ddd, J = 17.2, 2.7, 1.3 Hz,
1H), 5.21 (ddd, J = 10.4, 2.4, 1.2 Hz, 1H), 4.98−4.90 (m, 2H), 4.74
(tdd, J = 13.1, 5.8, 1.3 Hz, 1H), 4.71−4.64 (m, 1H), 3.32 (s, 3H),
2.84−2.70 (m, 1H), 2.03 (m, 1H); 13C NMR (100 MHz, CDCl3) δ
175.8, 166.5, 165.7, 149.2, 142.2, 131.7, 131.4, 131.1, 128.8, 129.7,
129.3, 129.0, 128.9, 125.6, 124.8, 122.5, 118.9, 108.5, 67.5, 65.4, 53.7,
30.2, 26.7; IR (neat ﬁlm NaCl) 2096, 1718, 1637, 1533, 1475, 1358,
1232, 1184, 760 cm−1; HRMS (MM: ESI-APCI+) m/z calcd for
C23H21N2O7 [M + H]
+ 437.1343, found 437.1298.
3′-Allyl-1-methyl-3′-(2-nitrophenyl)-5′,6′-dihydrospiro-
[indoline-3,4′-pyran]-2,2′(3′H)-dione (51). An oven-dried ﬂask
was charged with ester 50 (1.3 g, 3.05 mmol, 1.00 equiv), sealed with a
rubber stopper, and evacuated. The ﬂask was brought in a glovebox,
and Pd(PPh3)4 (84 mg, 75.0 μmol, 0.025 equiv) was added. The ﬂask
was brought out of the drybox and THF (60 mL) was added. The
reaction mixture was stirred for 5 min and concentrated under reduced
pressure. Column chromatography using a Teledyne Isco CombiFlash
Rf (SiO2, 80 g column, 25 → 50% EtOAc in hexanes) aﬀorded the
desired protected alkylation product 51 (1.1 g, 90% yield) as a
colorless solid: Rf = 0.40 (1:1 hexane/EtOAc);
1H NMR (400 MHz,
CDCl3) δ 7.63 (dd, J = 7.9, 1.6 Hz, 1H), 7.18 (dt, J = 7.8, 1.4 Hz, 1H),
7.12 (dt, J = 7.5, 1.7 Hz, 1H), 7.07 (dt, J = 7.7, 1.1 Hz, 1H), 7.00 (d, J
= 7.7 Hz, 1H), 6.85 (dd, J = 8.0, 1.3 Hz, 1H), 6.68 (d, J = 7.7 Hz, 1H),
6.64 (dt, J = 7.7, 1.0 Hz, 1H), 5.55 (tdd, J = 17.0, 10.2, 6.7 Hz, 1H),
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5.33 (ddd, J = 11.6, 10.0, 3.4 Hz, 1H), 5.01 (ddd, J = 17.1, 3.0, 1.5 Hz,
1H), 4.93 (ddd, J = 10.3, 2.7, 1.2 Hz, 1H), 4.68 (td, J = 11.6, 4.7 Hz,
1H), 3.45 (tdd, J = 15.6, 6.6, 1.3 Hz, 1H), 3.26 (s, 3H), 2.99 (tdd, J =
9.0, 6.9, 1.3 Hz, 1H), 2.87 (ddd, J = 14.6, 10.0, 4.6 Hz, 1H), 2.21 (ddd,
J = 14.7, 4.8, 3.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 177.3,
168.5, 149.8, 142.1, 133.9, 133.1, 131.1, 130.6, 130.4, 128.6, 127.8,
125.7, 124.8, 122.2, 119.0, 107.6, 64.8, 54.2, 54.0, 43.7, 30.7, 26.5; IR
(neat ﬁlm NaCl) 1701, 1614, 1531, 1473, 1356, 1300, 1259, 1202,
1105, 929, 739 cm−1; HRMS (MM: ESI-APCI+) m/z calcd for
C22H21N2O5 [M + H]
+ 393.1445, found 393.1458.
2-(4-Bromo-1-methyl-3′-(2-nitrophenyl)-2,2′-dioxo-
2′,3′,5′,6′-tetrahydrospiro[indoline-3,4′-pyran]-3′-yl)acetalde-
hyde (63). A solution of alkene 62 (47.1 mg, 100 μmol, 1.00 equiv) in
a mixture of CH2Cl2 (2.5 mL) and MeOH (2.5 mL) in a Schlenk ﬂask
hooked up to an ozone generator was purged with oxygen gas at −78
°C (5 min, ﬂow 0.25). Then the ozone generator was turned on (low−
medium setting), and an ozone/oxygen gas mixture was bubbled
through the reaction. The progress of the reaction was checked via
TLC (9:1 hexanes/CH2Cl2) in short time intervals (1−2 min). Upon
completion of the reaction, the mixture was purged with oxygen gas
for 5 min, and DMS (36.0 μg, 500 μmol, 5.00 equiv) was added. The
reaction mixture was slowly warmed to ambient temperature, and
stirred for 16 h. The residue was puriﬁed by column chromatography
(9:1 CH2Cl2:EtOAc) on silica gel to aﬀord aldehyde 63 (44 mg, 94%
yield): Rf = 0.28 (9:1 CH2Cl2/EtOAc);
1H NMR (500 MHz, DMSO-
d6) δ 8.64 (d, J = 3.4 Hz, 1H), 7.83−7.79 (m, 1H), 7.65−7.59 (m,
1H), 7.43−7.39 (m, 1H), 7.31 (t, J = 8.0 Hz, 1H), 7.21 (d, J = 7.9 Hz,
1H), 7.05 (d, J = 8.1 Hz, 1H), 6.92 (d, J = 8.3 Hz, 1H), 5.15 (ddd, J =
12.5, 10.8, 4.7 Hz, 1H), 4.59 (dd, J = 11.1, 6.9 Hz, 1H), 3.94 (ddd, J =
14.5, 12.6, 7.1 Hz, 1H), 3.22 (s, 3H), 3.08 (d, J = 17.0 Hz, 1H), 2.67
(dd, J = 17.0, 3.5 Hz, 1H), 1.96 (dd, J = 14.7, 4.6 Hz, 1H); 13C NMR
(125 MHz, DMSO) δ 198.0, 174.8, 171.0, 151.5, 146.3, 133.3, 131.9,
131.3, 129.9, 129.7, 127.6, 125.5, 124.6, 122.4, 109.3, 65.4, 55.6, 52.6,
49.8, 26.4, 22.3; IR (neat ﬁlm NaCl) 1695, 1600, 1528, 1458, 1354,
1294, 1222, 1118, 850, 787 cm−1; HRMS (MM: ESI-APCI+) m/z
calcd for C21H18BrN2O6 [M + H]
+ 473.0343, found 473.0346.
10-Bromo-10b-(2-hydroxyethyl)-2-(4-methoxybenzyl)-6-
methyl-4a-(2-nitrophenyl)-2,3,4,4a,6,10b-hexahydrobenzo[c]-
[2,6]naphthyridine-1,5-dione (65). To a suspension of aldehyde 63
(47.3 mg, 100 μmol, 1.00 equiv) and the acetic acid ammonium salt of
p-methoxybenzylamine (59.2 mg, 300 μmol, 3.00 equiv) in MeOH (4
mL) was added NaBH3CN (2.60 mg, 300 μmol, 3.00 equiv) in THF
(2 mL). The reaction mixture was stirred at ambient temperature for
16 h (conversion of the suspension to a clear, colorless solution usually
indicated the completion of the reaction) and then concentrated under
reduced pressure. Column chromatography using a Teledyne Isco
CombiFlash Rf (SiO2, 12 g column, 1. 1:1 → 1:4 hexanes/EtOAc)
yielded lactam 65 (39.7 mg, 67% yield) as a colorless solid: Rf = 0.12
(19:1 CH2Cl2/MeOH);
1H NMR (500 MHz, CDCl3) δ 9.10 (dd, J =
8.3, 1.4 Hz, 1H), 7.59−7.55 (m, 1H), 7.43 (ddd, J = 8.4, 7.3, 1.3 Hz,
1H), 7.36 (dd, J = 8.0, 1.6 Hz, 1H), 7.17 (t, J = 7.9 Hz, 1H), 7.10 (dd,
J = 8.2, 1.0 Hz, 1H), 7.06−7.02 (m, 2H), 6.81−6.76 (m, 3H), 4.71 (d,
J = 14.6 Hz, 1H), 3.98 (d, J = 14.6 Hz, 1H), 3.76 (s, 3H), 3.53−3.49
(m, 1H), 3.18 (s, 3H), 3.16−3.08 (m, 3H), 2.90 (ddd, J = 9.6, 8.5, 3.2
Hz, 1H), 2.78 (dt, J = 9.6, 7.3 Hz, 1H), 2.25 (ddd, J = 14.1, 7.1, 3.1 Hz,
1H), 2.14 (ddd, J = 14.0, 8.6, 7.6 Hz, 1H); 13C NMR (125 MHz,
CDCl3) δ 177.7, 171.7, 159.2, 152.6, 147.2, 134.4, 130.9, 130.4, 130.3,
129.9, 129.0, 128.0, 127.9, 126.3, 125.5, 122.4, 114.1, 107.3, 60.1, 58.5,
55.7, 55.4, 47.4, 44.0, 32.1, 27.5, 26.8; IR (neat ﬁlm NaCl) 3459, 2931,
1682, 1601, 1574, 1530, 1457, 1360, 1249, 1176, 1037, 910, 849, 783,
731 cm−1; HRMS (MM: ESI-APCI+) m/z calcd for C29H29BrN3O6
[M + H]+ 594.1234, found 594.1230.
Methyl (2-(3-(4-Bromo-1-methyl-2-oxo-3-(2-((triisopropyl-
silyl)oxy)ethyl)indolin-3-yl)-1-(4-methoxybenzyl)-2-oxo-
pyrrolidin-3-yl)phenyl)carbamate (54). To a solution of aldehyde
69 (100 mg, 0.15 mmol, 1.00 equiv) and (p-methoxybenzyl)-
ammonium acetate (90 mg, 0.46 mmol, 3.00 equiv) in methanol
(7.6 mL) was added NaBH3CN (21 mg, 0.30 mmol, 2.00 equiv) in
THF (3.8 mL) at 0 °C. The reaction mixture was slowly warmed to 23
°C and stirred overnight. The reaction mixture was washed with
EtOAc (3 × 10 mL), and brine. The combined organic phases were
dried over MgSO4 and concentrated in vacuo. The residue was puriﬁed
by column chromatography (4:1 hexanes/EtOAc) on silica gel to
aﬀord lactam 54 (112 mg, 95% yield): Rf = 0.20 (4:1 hexanes/EtOAc);
1H NMR (500 MHz, CDCl3) δ 12.14 (s, 1H), 8.00 (d, J = 8.3 Hz,
1H), 7.18 (d, J = 8.3 Hz, 2H), 7.15−7.10 (m, 2H), 7.05 (q, J = 8.5, 7.9
Hz, 2H), 6.88 (t, J = 7.7 Hz, 1H), 6.85−6.80 (m, 2H), 6.49 (d, J = 7.7
Hz, 1H), 4.80 (d, J = 14.4 Hz, 1H), 4.36 (d, J = 14.4 Hz, 1H), 3.78 (s,
3H), 3.70 (s, 1H), 3.63 (s, 3H), 3.52 (td, J = 6.9, 3.6 Hz, 1H), 3.43−
3.36 (m, 1H), 3.27 (td, J = 9.3, 5.7 Hz, 1H), 3.17 (t, J = 9.6 Hz, 1H),
2.87 (ddd, J = 13.3, 6.1, 3.5 Hz, 1H), 2.66−2.60 (m, 1H), 2.56 (s, 3H),
2.54−2.49 (m, 1H), 0.85 (q, J = 3.8 Hz, 21H); 13C NMR (125 MHz,
CDCl3) δ 175.94, 173.92, 159.34, 154.32, 146.89, 139.65, 132.30,
130.98, 130.07, 129.75, 128.88, 128.50, 127.57, 127.42, 126.71, 126.45,
121.74, 120.99, 120.75, 114.18, 107.15, 68.21, 61.31, 60.86, 60.43,
55.34, 51.42, 47.61, 44.98, 31.20, 25.78, 17.86, 11.88; IR (neat ﬁlm
NaCl) 2944, 2865, 2073, 1716, 1667, 1604, 1513, 1455, 1247, 1227,
1109, 1069, 1034, 883, 761 cm−1; HRMS (MM: ESI-APCI+) m/z
calcd for C40H53BrN3O6Si [M + H]
+ 778.2882, found 778.2879.
Methyl 3a-(4-Bromo-1-methyl-2-oxo-3-(2-((triisopropyl-
silyl)oxy)ethyl)indolin-3-yl)-1-(4-methoxybenzyl)-2,3,3a,8a-
tetrahydropyrrolo[2,3-b]indole-8(1H)-carboxylate (71). To a
solution of amide 54 (0.32 g, 0.41 mmol, 1.00 equiv) in THF (41.1
mL) was added AlH3−Me2NEt (0.5 M in toluene; 1.64 mL, 0.82
mmol, 2.00 equiv) dropwise at 0 °C. The reaction was stirred for 2 h
and quenched with MeOH. The reaction solution was concentrated in
vacuo and puriﬁed by column chromatography (4:1 hexanes/EtOAc)
to aﬀord aminal 71 (0.19 g, 61% yield): Rf = 0.20 (4:1 hexanes/
EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.58−7.47 (m, 1H), 7.21 (d,
J = 8.2 Hz, 2H), 7.04−6.93 (m, 3H), 6.80 (dq, J = 14.8, 7.4 Hz, 4H),
6.39−6.24 (m, 2H), 4.30 (m, 1H), 3.92−3.79 (m, 4H), 3.78 (s, 3H),
3.68 (dd, J = 10.2, 5.0 Hz, 1H), 3.57−3.43 (m, 1H), 3.03 (s, 3H), 2.65
(m, 4H), 2.26 (dt, J = 15.0, 7.2 Hz, 1H), 2.09 (dd, J = 11.9, 4.6 Hz,
1H), 0.87 (d, J = 3.2 Hz, 21H); 13C NMR (125 MHz, CDCl3) δ 176.0,
175.7, 160.6, 146.3, 141.7, 133.9, 132.2, 130.3, 130.1, 126.8, 123.6,
123.2, 123.1, 115.1, 114.6, 113.9, 107.3, 107.1, 106.6, 82.4, 60.7, 60.1,
57.2, 55.3, 52.6, 51.0, 31.9, 31.1, 30.7, 29.7, 26.1, 17.7, 11.8; IR (neat
ﬁlm NaCl) 2943, 1722, 1604, 1464, 1386, 1344, 1254, 1107, 1033,
885, 760 cm−1; HRMS (MM: ESI-APCI+) m/z calcd for
C40H53BrN3O5Si [M + H]
+ 762.2932, found 762.2936.
Methyl 3a-(4-Bromo-3-(2-hydroxyethyl)-1-methyl-2-oxoin-
dolin-3-yl)-2,3,3a,8a-tetrahydropyrrolo[2,3-b]indole-8(1H)-car-
boxylate (72). To a solution of silyl ether 71 (98 mg, 0.13 mmol,
1.00 equiv) in THF (1.28 mL) was added TBAF (0.15 mL, 1.0 M
solution in THF) at 0 °C. The reaction mixture was stirred for 3 h at
23 °C and quenched with satd NH4Cl. The reaction mixture was
washed with EtOAc (3 × 1.5 mL) and brine. The combined organic
phases were dried over MgSO4 and concentrated in vacuo. The residue
was puriﬁed by column chromatography (2:1 hexanes/EtOAc) on
silica gel to aﬀord PMB-protected aminal compound (78 mg, 98%
yield).
To a solution of PMB-protected aminal compound (96 mg, 0.16
mmol, 1.00 equiv) in CH2Cl2 (3.1 mL) and H2O (0.8 mL) was added
DDQ (53 mg, 0.23 mmol, 1.50 equiv) in portions over 30 min at 0 °C.
The reaction mixture was stirred for 2 h at 23 °C. The solution was
diluted with CH2Cl2 and quenched with satd NaHCO3. The reaction
mixture was washed with CH2Cl2 (3 × 2.5 mL) and brine. The
combined organic phases were dried over MgSO4, and concentrated in
vacuo. The residue was puriﬁed by column chromatography (4:1
CH2Cl2/acetone) on silica gel to aﬀord aminal 72 (64 mg, 85% yield):
Rf = 0.31 (4:1 CH2Cl2/acetone);
1H NMR (600 MHz, CDCl3) δ 7.50
(d, J = 8.1 Hz, 1H), 7.01−6.96 (m, 2H), 6.84 (p, J = 8.6 Hz, 1H), 6.78
(d, J = 7.6 Hz, 1H), 6.73 (t, J = 7.5 Hz, 1H), 6.48 (s, 1H), 6.35 (d, J =
7.8 Hz, 1H), 3.87 (d, J = 17.2 Hz, 3H), 3.66 (ddd, J = 10.8, 6.8, 3.7 Hz,
1H), 3.35 (dt, J = 10.9, 5.3 Hz, 1H), 3.11 (s, 3H), 3.01 (dd, J = 10.0,
6.5 Hz, 1H), 2.80−2.76 (m, 1H), 2.76−2.62 (m, 2H), 2.50 (td, J =
10.3, 4.7 Hz, 1H), 2.24 (br, s, 1H), 2.20 (dd, J = 12.7, 4.8 Hz, 1H); 13C
NMR (125 MHz, CDCl3) δ 177.6, 152.8, 146.1, 142.7, 130.4, 129.7,
128.9, 127.4, 127.2, 122.8, 121.6, 118.5, 113.8, 106.8, 80.5, 63.4, 60.0,
57.2, 52.6, 44.6, 35.1, 31.5, 26.3; IR (neat ﬁlm NaCl) 3417, 2925,
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1710, 1604, 1487, 1458, 1392, 1362, 1272, 1093, 756 cm−1; HRMS
(MM: ESI-APCI+) m/z calcd for C23H25BrN3O4 [M + H]
+ 486.1023,
found 486.1014.
Methyl (2-(1-(4-Methoxybenzyl)-3-(1-methyl-2-oxo-3-(2-
((triisopropylsilyl)oxy)ethyl)indolin-3-yl)-2-oxopyrrolidin-3-yl)-
phenyl)carbamate (73). To a solution of lactam 54 (10.6 mg,
0.0136 mmol, 1.00 equiv) in THF (1.36 mL) was added LiAlH4 (5.2
mg, 0.136 mmol, 10.0 equiv) in portions at 0 °C. The reaction was
stirred for 1 h and then quenched with satd NaCl. The reaction
mixture was washed with EtOAc (3 × 2 mL) and brine. The combined
organic phases were dried over MgSO4 and concentrated in vacuo.
The residue was puriﬁed by column chromatography (4:1 hexanes/
EtOAc) to aﬀord oxindole 73 (7.9 mg, 83% yield): Rf = 0.25 (4:1
hexanes/EtOAc); 1H NMR (600 MHz, CDCl3) δ 9.64 (br, s, 1H),
8.02 (d, J = 7.5 Hz, 1H), 7.60 (br, s, 1H), 7.13 (d, J = 8.4 Hz, 3H),
7.09 (t, J = 7.6 Hz, 1H), 7.04 (t, J = 7.7 Hz, 1H), 6.97 (s, 1H), 6.83 (d,
J = 8.3 Hz, 3H), 6.38 (d, J = 7.7 Hz, 1H), 4.55 (d, J = 14.5 Hz, 1H),
4.44 (d, J = 14.5 Hz, 1H), 3.77 (s, 3H), 3.71 (s, 3H), 3.31−3.27 (m,
1H), 3.24 (br, s, 2H), 3.14 (br, s, 1H), 3.05−3.00 (m, 1H), 2.85 (s,
3H), 2.72 (br, s, 1H), 2.52 (m, 1H), 2.41 (br, s, 1H), 0.86 (q, J = 7.5,
6.2 Hz, 21H); 13C NMR (125 MHz, CDCl3) δ 177.5, 159.4, 154.7,
143.7, 129.6, 129.4, 129.3, 129.2, 128.6, 128.4, 127.7, 127.5, 127.4,
122.2, 122.0, 121.8, 114.3, 107.3, 60.0, 56.6, 55.4, 52.1, 47.1, 44.0, 34.3,
29.9, 26.0, 18.0, 12.0; IR (neat ﬁlm NaCl) 2941, 1732, 1711, 1610,
1515, 1442, 1375, 1248, 1225, 1105, 1070, 1036, 750 cm−1; HRMS
(MM: ESI-APCI+) m/z calcd for C40H54N3O6Si [M + H]
+ 700.3776,
found 700.3776.
Methyl 4-Bromo-10′-(4-methoxybenzyl)-1-methyl-2-oxo-
2′,3′-dihydro-9′H-spiro[indoline-3,4′-[9a,4a](epiminoethano)-
pyrano[2,3-b]indole]-9′-carboxylate (76). To a solution of lactam
54 (70 mg, 0.090 mmol, 1.00 equiv) in CH2Cl2 (9 mL) was added
Tf2O (45 mL, 0.27 mmol, 3.00 equiv) dropwise at 0 °C. The reaction
mixture was slowly warmed to 23 °C and stirred for 2 h. The solution
was neutralized by adding satd NaHCO3. The reaction mixture was
washed with CH2Cl2 (3 × 5 mL) and brine. The combined organic
phases were dried over MgSO4 and concentrated in vacuo. The residue
was puriﬁed by column chromatography (2:1 hexanes/EtOAc) on
silica gel to aﬀord propellane hexacycle 76 (52 mg, 95% yield): Rf =
0.25 (3:1 hexanes/EtOAc); 1H NMR (500 MHz, CDCl3) δ 7.67 (s,
1H), 7.16−7.11 (m, 3H), 6.95−6.93 (m, 2H), 6.78 (d, J = 8.6 Hz,
2H), 6.73 (td, J = 7.6, 1.1 Hz, 1H), 6.60 (t, J = 4.4 Hz, 1H), 6.36 (dd, J
= 7.6, 1.5 Hz, 1H), 4.53 (dt, J = 11.5, 5.8 Hz, 1H), 4.47 (d, J = 14.9
Hz, 1H), 4.23−4.18 (m, 1H), 3.87 (s, 3H), 3.76 (s, 3H), 3.72 (d, J =
13.7 Hz, 1H), 3.21 (s, 3H), 3.01 (ddd, J = 14.4, 11.7, 8.4 Hz, 1H),
2.77−2.73 (m, 1H), 2.54 (q, J = 9.3 Hz, 1H), 2.13 (td, J = 8.8, 5.3 Hz,
1H), 1.93 (dd, J = 14.2, 6.3 Hz, 1H), 1.80−1.75 (m, 1H); 13C NMR
(125 MHz, CDCl3) δ 178.0, 158.5, 153.7, 145.8, 142.5, 132.0, 130.9,
130.1, 129.5, 129.4, 128.9, 128.1, 124.6, 122.9, 121.5, 116.1, 113.6,
112.1, 106.6, 58.2, 57.0, 55.4, 54.4, 52.7, 50.2, 47.9, 33.7, 26.6, 23.2; IR
(neat ﬁlm NaCl) 1718, 1601, 1575, 1513, 1484, 1455, 1365, 1245,
1134, 1099, 1037, 912, 764, 731 cm−1; HRMS (MM: ESI-APCI+) m/z
calcd for C31H31BrN3O5 [M + H]
+ 604.1442, found 604.1433.
Methyl 4-Bromo-1-methyl-2-oxo-2′,3′-dihydro-9′H-spiro-
[indoline-3,4′-[9a,4a](epiminoethano)pyrano[2,3-b]indole]-9′-
carboxylate (77). To a solution of oxindole 76 (46 mg, 0.075 mmol,
1.00 equiv) in CH2Cl2 (3.8 mL) and H2O (0.94 mL) was added DDQ
(34 mg, 0.15 mmol, 2.00 equiv) at 0 °C. The reaction mixture was
slowly warmed to 23 °C and stirred for 2 h. The solution was
quenched with satd NaHCO3. The reaction mixture was washed with
CH2Cl2 (3 × 3.0 mL) and brine. The combined organic phases were
dried over MgSO4 and concentrated in vacuo. The residue was puriﬁed
by column chromatography (4:1 CH2Cl2/acetone) on silica gel to
aﬀord propellane hexacycle 77 (33 mg, 92% yield): Rf = 0.1 (1:1
hexane/EtOAc); 1H NMR (500 MHz, CDCl3) δ 7.70 (d, J = 8.2 Hz,
1H), 7.16 (ddd, J = 8.3, 7.4, 1.4 Hz, 1H), 7.03 (dd, J = 8.2, 7.6 Hz,
1H), 6.95 (dd, J = 8.2, 1.1 Hz, 1H), 6.72 (ddd, J = 14.7, 7.6, 1.1 Hz,
2H), 6.26 (ddd, J = 7.6, 1.4, 0.5 Hz, 1H), 4.47 (td, J = 11.2, 6.6 Hz,
1H), 4.12−4.07 (m, 1H), 3.93 (s, 3H), 3.23 (s, 3H), 3.14 (dd, J = 9.4,
6.0 Hz, 1H), 3.00 (ddd, J = 14.4, 11.2, 8.2 Hz, 1H), 2.68−2.57 (m,
2H), 1.89−1.85 (m, 1H), 1.82 (ddd, J = 14.4, 6.6, 1.6 Hz, 1H); 13C
NMR (125 MHz, CDCl3) δ 177.9, 153.6, 145.8, 142.4, 133.3, 130.4,
129.7, 129.2, 128.1, 125.7, 123.2, 122.5, 114.3, 111.6, 106.9, 58.5, 55.7,
53.8, 53.0, 43.3, 36.5, 26.6, 23.5; IR (neat ﬁlm NaCl) 2958, 1713,
1602, 1485, 1446, 1373, 1242, 1095, 754 cm−1; HRMS (MM: ESI-
APCI+) m/z calcd for C23H23BrN3O4 [M + H]
+ 484.0866, found
484.0874.
Methyl 10-Bromo-10b-(2-hydroxyethyl)-1′-(4-methoxyben-
zyl)-6-methyl-2′-oxo-6,10b-dihydrospiro[indolo[2,3-b]-
quinoline-11,3′-pyrrolidine]-5(5aH)-carboxylate (81). To a
solution of propellane hexacycle 76 (13 mg, 0.021 mmol, 1.00
equiv) in CH2Cl2 (2.14 mL) was added DIBAL (1.0 M in THF; 0.11
mL, 0.11 mmol, 5.00 equiv) dropwise at −78 °C. The reaction mixture
was stirred for 1 h and warmed to 0 °C. DIBAL (1.0 M in THF; 21.4
mL, 21.4 mmol, 1.00 equiv) was added dropwise at 0 °C and the
mixture stirred for 1 h. Then, DIBAL (1.0 M in THF; 21.4 mL, 21.4
mmol, 1.00 equiv) was added one more time dropwise at 0 °C and the
mixture stirred for another 1 h. The reaction mixture was warmed to
23 °C, and Et2AlCl (1.0 M in hexane; 42.8 mL, 42.8 mmol, 2.00 equiv)
was added dropwise. The mixture was stirred for 30 min and quenched
with satd NH4Cl and satd potassium sodium tartrate. The reaction
mixture was washed with CH2Cl2 (3 × 2.0 mL) and brine. The
combined organic phases were dried over MgSO4 and concentrated in
vacuo. The residue was puriﬁed by column chromatography (1:1
hexane/EtOAc) on silica gel to aﬀord aminal 81 (10.5 mg, 87% yield):
Rf = 0.25 (1:1 hexane/EtOAc);
1H NMR (500 MHz, CDCl3) δ 7.39
(d, J = 7.7 Hz, 1H), 7.24−7.22 (m, 2H), 7.17 (m, 1H), 7.08−7.03 (m,
1H), 6.87−6.84 (m, 2H), 6.82 (t, J = 7.9 Hz, 1H), 6.71 (dd, J = 8.0, 1.0
Hz, 1H), 6.23 (br, s, 1H), 6.01 (dd, J = 7.9, 1.0 Hz, 1H), 5.15 (d, J =
14.5 Hz, 1H), 3.94 (d, J = 14.5 Hz, 1H), 3.84 (s, 3H), 3.79 (s, 3H),
3.72−3.63 (m, 2H), 3.40 (dd, J = 9.5, 7.7 Hz, 1H), 3.12 (td, J = 9.7,
1.5 Hz, 1H), 3.10−3.04 (m, 1H), 2.89−2.82 (m, 1H), 2.48 (s, 3H),
2.32 (dt, J = 14.2, 7.2 Hz, 1H), 1.65 (dt, J = 14.7, 9.7 Hz, 1H), 1.59
(br, s, 1H); 13C NMR (125 MHz, CDCl3) δ 170.5, 159.2, 152.7, 139.2,
136.3, 134.0, 130.4, 129.8, 128.8, 126.8, 126.7, 126.1, 125.2, 125.0,
122.9, 122.4, 114.2, 104.7, 83.3, 61.0, 60.5, 55.4, 53.6, 53.4, 47.1, 44.3,
35.3, 33.0, 31.1; IR (neat ﬁlm NaCl) 2922, 1689, 1597, 1512, 1444,
1334, 1249, 1178, 1032, 754 cm−1; HRMS (MM: ESI-APCI+) m/z
calcd for C31H33BrN3O5 [M + H]
+ 606.1598, found 606.1592.
8′-Bromo-1-methyl-1″-(2-nitrobenzyl)-2′,3′-dihydro-1′H-
dispiro[indoline-3,4′-benzo[b]azepine-5′,3″-pyrrolidine]-2,2″-
dione (91). To a solution of amide 89 (20 mg, 0.0239 mmol, 1.00
equiv) in CH2Cl2 (2.39 mL), was added Tf2O (0.0121 mL, 0.0718
mmol, 3.00 equiv) dropwise at 0 °C. The reaction mixture was slowly
warmed to 23 °C and the mixture stirred for 2 h. After the reaction
was complete, the solution was brought to pH 10.5−11.0 by addition
of satd NaHCO3. The reaction mixture was extracted with EtOAc (3 ×
3 mL) and washed with brine. The combined organic phases were
dried over MgSO4 and concentrated in vacuo. The residue was puriﬁed
by column chromatography (2:1 hexanes/EtOAc) on silica gel to
aﬀord tetrahydroazepine 91 (9.4 mg, 70% yield): Rf = 0.33 (2:1
hexanes/EtOAc); 1H NMR (600 MHz, CDCl3) δ 8.04 (d, J = 8.1 Hz,
1H), 7.69 (t, J = 7.6 Hz, 1H), 7.53 (d, J = 7.8 Hz, 1H), 7.43 (t, J = 7.8
Hz, 1H), 7.19 (t, J = 7.7 Hz, 1H), 7.09 (d, J = 2.1 Hz, 1H), 6.98 (dd, J
= 8.3, 2.0 Hz, 1H), 6.82 (d, J = 7.8 Hz, 1H), 6.73 (t, J = 7.7 Hz, 1H),
6.70 (dd, J = 8.4, 1.3 Hz, 1H), 6.18 (d, J = 7.6 Hz, 1H), 5.08 (d, J =
17.0 Hz, 1H), 4.47 (d, J = 17.0 Hz, 1H), 3.89 (br, s, 1H), 3.78 (q, J =
13.0, 12.0 Hz, 1H), 3.31−3.26 (m, 2H), 3.23 (td, J = 9.3, 8.5, 4.1 Hz,
1H), 3.18 (s, 3H), 2.96−2.89 (m, 2H), 2.70 (dt, J = 13.5, 8.5 Hz, 1H),
1.42 (d, J = 13.3 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 180.4,
175.1, 150.3, 148.3, 143.8, 134.2, 132.5, 131.1, 131.1, 129.4, 129.2,
128.3, 127.7, 126.0, 125.3, 125.0, 124.6, 121.7, 121.3, 108.0, 58.8, 50.3,
44.6, 44.1, 43.4, 36.1, 27.6, 26.4; IR (neat ﬁlm NaCl) 3343, 2942,
1703, 1611, 1588, 1524, 1471, 1357, 1285, 1137, 1106, 1065, 984, 858,
732 cm−1; HRMS (MM: ESI-APCI+) m/z calcd for C28H26BrN4O4
[M + H]+ 561.1132, found 561.1165.
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